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The aquatic environment is the main destination for many organic pollutants originating 
from human activity. Pharmaceuticals are significant contributors to this pollutant 
cocktail. One major route of pharmaceuticals into the aquatic environment is through 
discharges from sewage treatment plants (STPs) with inadequate pharmaceutical 
removal capacity. Adverse effects in aquatic organisms exposed to pharmaceuticals have 
been illustrated in a multitude of studies. Advanced sewage treatment technologies are 
therefore being evaluated as potential methods for improving pharmaceutical removal, 
for example whole-effluent ozonation. However, it remains important to assess how the 
ozonation treatment modulates the biological effect in aquatic organisms exposed to the 
STP effluent due to the formation of ozonation by-products (OBPs).  
This thesis aimed to investigate outcomes of ozonation treatment of STP effluents with 
a special focus on pharmaceuticals, by combining chemical analysis and in vivo testing 
using zebrafish (Danio rerio). Firstly the effects of an ozonated STP effluent on 
reproduction and behavior of adult zebrafish were evaluated at a Swedish STP (Knivsta 
municipal STP) with a full-scale ozonation step. Fish exposed over 21 days to the 
ozonated STP effluent spawned significantly more eggs than fish exposed to the non-
ozonated effluent and tap water. Vitellogenin induction (a biomarker for estrogenic 
pollutants) and a possible anxiety-related behavior were also observed in fish exposed to 
the ozonated STP effluent. Chemical analysis of the pre- and post ozonated STP effluent 
was used to screen for the presence of 105 pharmaceuticals, of which 24 could be 
detected. The average ozone removal efficiency of these pharmaceuticals was 77%.   
The thesis work then focused on how ozonation would affect zebrafish embryotoxicity 
of three pharmaceuticals detected in the Knivsta STP effluent (i.e. carbamazepine, 
diclofenac, and oxazepam). While embryotoxicity of diclofenac was eliminated, 
exposure to oxazepam and carbamazepine induced embryotoxic responses following 
ozonation, suggesting formation of OBPs. The thesis therefore proceeded to investigate 
the toxicities of isolated carbamazepine OBPs. It was revealed that two carbamazepine 
OBPs, BQM and BQD, were the drivers of ozonated carbamazepine embryotoxicity. The 
thesis concludes that the formation of specific pharmaceutical OBPs explains adverse 
biological outcomes of effluent ozonation. The results add valuable information for the 
continuing efforts to improve STP effluent treatment.  
Keywords: Zebrafish, Sewage treatment, Pharmaceuticals, Ozonation-by-products 
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Abstract 
 
 
Vattenmiljön är slutdestinationen för många kemiska föroreningar av mänskligt 
ursprung, varav läkemedel är en viktig komponent. En väsentlig föroreningskälla är 
avloppsreningsverk vilka ofta saknar kapaciteten att effektivt avskilja läkemedelsrester. 
Flertalet studier har påvisat skadliga effekter av läkemedel i vattenlevande organismer. 
Nya avancerade avloppsreningsmotoder med potential att effektivt avskilja 
läkemedelsrester från avloppsvatten är under utredning. En av dessa metoder är 
ozonering av effluenten innan utsläpp i vattenmiljön. Ozonering av kemikalier, inklusive 
läkemedelsrester, kan dock potentiellt bilda toxiska ozonerings-restprodukter vilket gör 
det viktigt att studera de biologiska effekter som ozonering av avloppsvatten kan ha på 
vattenlevande organismer. 
Denna doktorsavhandling hade som mål att utvärdera biologiska och kemiska effekter 
av ozonering av avloppseffluenter och läkemedel. I detta syfte användes en kombination 
av analytisk kemi och in vivo tester med sebrafisk (Danio rerio). Först undersöktes 
reproduktionsförmåga och beteende i vuxna sebrafiskar som exponerats för ozonerad 
avloppseffluent under 21 dagar vid Knivsta reningsverk. Kemisk analys av effluenten 
visade att ozonbehandlingen reducerade i snitt 77 % av koncentrationerna av 24 
detekterade läkemedelssubstanser. Samtidigt hade fiskarna i den ozonerade effluenten 
bättre fekunditet än fiskar i den vanliga effluenten och kontrollgruppen. Vidare var 
genuttrycket av vitellogenin (en biomarkör för östrogena ämnen) inducerat och en 
förmodat stress-relaterad beteendeförändring uppmättes i dessa fiskar.  
 Avhandlingsarbetet fortsatte sedan undersöka ozonerat karbamazepin, diklofenak och 
oxazepam, läkemedel som förekom i Knivstaeffluenten. Ozonering reducerade 
diklofenaks embryotoxicitet men ökade toxiciteten av oxazepam och karbamazepin, 
vilket indikerade uppkomst av ozonerings-restprodukter. Vidare undersöktes därför vilka 
ozonerings-restprodukter som bidrog till den förstärkta embryotoxicititen av 
karbamazepin. Genom dessa försök konstaterades att två ozonerings-restprodukter, här 
kallade BQM och BQD, stod för ökningen av den embryotoxicitet som observerades 
efter ozonering av karbamazepin. Resultaten påvisar sammanfattningsvis att uppkomsten 
av specifika ozonerings-restprodukter förklarar ökad toxicitet av vissa läkemedel efter 
ozonering. Denna information är av vikt för det fortskridande arbetet att förbättra 
behandling av avloppsvatten med avseende på läkemedelsrester.   
Nyckelord: Sebrafisk, avloppsrening, läkemedel, ozonerings-restprodukter 
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1.1 Pharmaceutical residues in the aquatic environment  
Chemical pollution originating from human activities can be found in virtually 
any environmental compartment on earth. The surface water environment is the 
major end destination for many organic micropollutants (i.e. substances 
quantified at ng−μg L-1). Human and veterinary pharmaceuticals are among 
these so called ‘emerging’ contaminants commonly detected in surface water 
worldwide (Hughes et al. 2013; Luo et al. 2014; Beek et al. 2016). The 
therapeutic component of pharmaceuticals, the active pharmaceutical ingredient 
(API), is designed to interact with biological targets in the patient and to 
withstand transformation and elimination in the human body, before excretion. 
These characteristics have potentially problematic consequences in the 
environment as APIs can affect biological processes in a range of non-target 
aquatic organisms (Fent et al. 2006). Human drug target orthologues, meaning 
evolutionarily conserved drug target genes, are found in zebrafish (88%), 
Daphnia pulex (63%), and even in green algae Chlamydomonas reinhardtii 
(36%)  (Gunnarsson et al. 2008). 
A multitude of studies have provided evidence for hazardous effects in fish 
exposed to many different APIs. Some notable examples are intersex (i.e. 
hermaphroditism) caused by estrogenic compounds (Jobling et al. 1998; 
Woodling et al. 2006), altered behaviors in wild fish exposed to benzodiazepines 
(Brodin et al. 2013; Klaminder et al. 2019), and kidney lesions in fish exposed 
to diclofenac (Mehinto et al. 2010; Näslund et al. 2017). Pharmaceuticals may 
undergo biotransformation in the patient or environmental biota, in some cases 
increasing their toxicity to aquatic organisms. For instance, diclofenac can 
undergo methylation in the aquatic invertebrates Gammarus pulex and Hyalella 
1 Introduction 
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asteca, and in fish hepatocytes, leading to a 430-fold increase in acute toxicity 
of methylated diclofenac compared to the parent compound (Fu et al. 2020).  
Pharmaceutical pollution has gained attention as a key global environmental 
issue requiring prioritization (Boxall et al. 2012). The European Union has 
acknowledged the issue by including diclofenac, 17β-estradiol (E2), 17α-
ethinylestradiol (EE2), and three macrolide antibiotics in the Water Framework 
Directive (WFD) list of candidate micropollutants that warrant environmental 
monitoring (European Union, 2015). It has been estimated that some 
pharmaceuticals, including diclofenac and EE2, are present in several Swedish 
surface water environments at concentrations exceeding the water quality 
standards stipulated in the WFD depending on sampling location and time 
(Lindim et al. 2019). 
Approximately 7500 pharmaceuticals are available on the global market 
today (The Royal Pharmaceutical Society, 2020). The European Medicine 
agency introduced environmental risk assessments (ERA) for all new 
pharmaceuticals developed from the year 2006. The back-catalog of ‘legacy’ 
pharmaceuticals (marketed before 2006) that are lacking environmental risk data 
are currently numbering 800 (Gunnarsson et al. 2019). An ERA of a new 
pharmaceutical is performed if the predicted environmental concentration (based 
on consumption data and dilution factors) exceeds 0.01 μg L-1, if the molecule 
is lipophilic (logKow ≥ 4.5), or has suspected reproductive endocrine-disrupting 
properties (European Medicines Agency, 2006). An API can however not be 
barred from release to the market based on environmental concerns (European 
Medicines Agency, 2006).  
Several issues regarding the ERA of pharmaceuticals have been raised. 
Ågestrand and co-workers have presented 10 recommendation to refine the ERA 
guideline, for instance inclusion of additional endpoints such as neurotoxicity 
and behavioral effects when assessing the environmental risks of 
pharmaceuticals, and to include the environmental aspect in the risk-benefit 
analysis of a new pharmaceutical before approval (Ågerstrand et al. 2015). 
Furthermore, as the assessments are based mainly on acute toxicity tests, there 
may be an underestimation of risk since aquatic organisms are often exposed 
chronically to pharmaceuticals (Ågerstrand et al. 2015). The actual internal 
concentrations of pharmaceuticals and their biotransformation products can be 
higher in the organisms than in their surrounding aquatic habitat, potentially 
underestimating environmental risk (Miller et al. 2018, 2019). Several 
pharmaceuticals have been shown to accumulate in fish blood plasma and other 
tissues (Fick et al. 2010; Zenker et al. 2014). The interaction effects of APIs may 
also increase the combined risk of pharmaceutical pollution, as the surface water 
environment generally contains a mixture of several pharmaceuticals (Backhaus, 
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2014). The environmental risks of mixtures is an area needing attention, 
highlighted in a recent statement by (Drakvik et al. 2020).  
1.2 Sewage treatment plants – major sources of 
pharmaceutical pollution 
A major contributor to pharmaceutical pollution is sewage treatment plant (STP) 
effluents which constantly flow into surface water. Raw sewage influent from 
industries, hospitals, and households generally contains a mixture of 
pharmaceuticals parent compounds and metabolites from a range of therapeutic 
classes (Luo et al. 2014). As an example, domestic and hospital sewage in Umeå, 
Sweden, contained 51 APIs at quantifiable concentrations, out of 105 analyzed 
(Lindberg et al. 2014). In Sweden, about 95% of sewage water is processed at 
STPs with chemical and biological treatment steps (Swedish Environmental 
Protection Agency, 2014). These sewage treatment steps are designed to remove 
phosphorus, nitrogen, and organic materials, in order to decrease bacterial 
concentrations and prevent eutrophication of the receiving water body. Many 
organic micropollutants, including pharmaceuticals, are however not readily 
removed by current ‘conventional’ treatment steps (Verlicchi et al. 2012). 
Further, de-conjugation of excreted conjugated pharmaceuticals may even 
increase concentrations of certain pharmaceuticals (e.g. antibiotics and 
carbamazepine) in sewage effluent as compared with sewage influent (Vieno et 
al. 2007; Gros et al. 2010).  
Activated sewage sludge methods can increase microbial degradation of 
certain pharmaceuticals, like ibuprofen, naproxen and ketoprofen (Falås et al. 
2012). Different types of filters can also aid in the removal of pharmaceuticals. 
Activated carbon filters with biofilm, e.g. granulated active carbon (GAC) or 
powder activated carbon (PAC), are able to physically adsorb and biologically 
degrade pharmaceuticals (Sbardella et al. 2018). PAC dosing in combination 
with moving bed biofilm reactors (MMBRs) can further improve the removal of 
pharmaceuticals (Cimbritz et al. 2019). About 25% of the produced sewage 
sludge is used as fertilizer on fields in Sweden (Statistics Sweden, 2012). 
Pharmaceuticals adsorbed in sewage sludge could potentially lead to terrestrial 
pharmaceutical pollution at agricultural sites where the sludge is used as 
fertilizer (Kümmerer, 2010; Ivanová et al. 2018). Studies on soil retention of 
pharmaceuticals have indicated persistence of several pharmaceuticals, 
including some psychoactive APIs (Magnér et al. 2016). 
Pharmaceutical production sites are today largely located in Asia, where the 
situation regarding pharmaceutical pollution is considerably worse than in 
Sweden. Instead of pharmaceutical concentrations at the ng−μg L-1 range, some 
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sewage effluents and adjacent water bodies in Asia can have concentrations 
exceeding mg L-1 levels (Larsson 2014). As an example, an STP located in a 
heavily industrialized part of Hyderabad, India, produced an effluent containing 
1 000 000–fold higher concentrations of the antimicrobial ciprofloxacin 
compared with average content in effluents from Swedish STPs (Larsson et al. 
2007). Ecotoxicity screenings of water collected at these locations indicated  
sublethal effects in amphibian tadpoles (Carlsson et al. 2009) and fish 
(Gunnarsson et al. 2009a) already at 0.2% dilution. Highly urbanized areas with 
dense populations can also produce STP effluents with elevated pharmaceutical 
concentrations, potentially leading to high pollution loads locally (Beek et al. 
2016). Interestingly, chemical screening of sewage effluents can reveal 
consumption patterns of illicit narcotic drugs; a study on STP effluent water 
collected during seven music festivals in the Czech and Slovak Republics could 
associate different classes of drugs to specific music genres, Ecstasy 
concentrations peaked for example during an electronic dance festival 
(Mackuľak et al. 2019). These types of psychotropic drugs can also cause 
distinct behavioral effects in fish (Neelkantan et al. 2013).  
The Swedish Environmental Protection Agency, together with some of 
Sweden’s county administrative boards, has commissioned screening studies of 
pharmaceutical residues in sewage influent, effluents, sludge, recipient waters, 
and fish tissues. These screenings have reported high concentrations of 
pharmaceuticals in sewage effluents and sewage sludge, and the presence of 
pharmaceuticals and estrogens in wild fish bile (Fick et al. 2011, 2014). The 
concentrations of some pharmaceuticals measured in surface water in these 
screenings exceeded the predicted pharmacological effect concentrations (Fick 
et al. 2010).  
1.3 Ozonation – a method to improve pharmaceutical 
removal in sewage effluents 
The presence of micropollutants in STP effluents is prompting mitigation 
measures such as improved sewage treatment (Eggen et al. 2014). One potential 
treatment technology is ozonation. Ozonation has been used for water treatment 
since the 19th century in both the United States (McGuire, 2006) and Europe 
(Paulouë & Langlais 1999). The fate of the ozonated pharmaceuticals and other 
organic molecules present in the STP effluent is dependent on a multitude of 
factors including ozone dose and composition of the effluent (Antoniou et al. 
2013; Zucker et al. 2015). Ozone directly targets and oxidases electron-rich 
moieties in the ozonated molecule. Ozonation of sewage effluents, which 
generally contain high concentrations of dissolved organic matter, produce 
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hydroxide-radicals that proceed to non-selectively degrade organic molecules, 
such as pharmaceuticals (Buffle et al. 2006). The ozonation process also forms 
many potentially toxic ozonation by-products (OBPs), e.g. aldehydes, ketones, 
and carboxylic acids (Hammes et al. 2006; Wert et al. 2007), bromate (von 
Gunten & Hoigne 1994), and N,N-dimethylsulfamide (Schmidt & Brauch 2008).  
Experimental studies have reported efficient pharmaceutical elimination of 
e.g. diclofenac and carbamazepine by ozonation (Huber et al. 2005; Buffle et al. 
2006). Investigations on full-scale ozonation steps integrated at STP have also 
shown potential in drastically improving pharmaceutical removal (Baresel et al. 
2016; Bourgin et al. 2018). Pharmaceutical ozonation will not necessarily lead 
to complete mineralization, but rather formation of a multitude of OBPs. While 
novel chemical analysis methodologies have increased the knowledge of OBPs 
formation and reaction kinetics, there are data gaps regarding the toxicities of 
these kinds of compounds (Cwiertny et al. 2014; von Gunten, 2018). The present 
thesis work, therefore, focused on this aspect in Papers II and III.   
1.4 Knivsta STP full-scale ozonation pilot plant 
The Swedish government proposition 2013/14:1 allocated 32 million Swedish 
crowns to the Swedish Agency for Marine and Water Management (SwAM) in 
order to stimulate research and development of advanced sewage treatment for 
removal of pharmaceuticals and other micropollutants. SwAM proceeded to 
grant eight projects that ran between 2014 and 2017 (see Cimbritz & Mattsson 
(2018) for project summaries). One of the funded projects, ‘Evaluation of 
Advanced Treatment in Full-scale’, was located at Knivsta municipal STP and 
was the first operational full-scale effluent ozonation plant constructed in 
Sweden in late 2014 (Björlenius 2018). The SwAM-funded project included 
chemical analysis of pharmaceuticals in pre- and post-ozonated effluent, 
ecological status in the recipient stream  (Knivstaån) before and after the 
ozonation campaign, impacts on pathogenic virus and bacteria by ozonation of 
the effluent, and biological effects in fish (part of the thesis work, Paper I).  
1.5 The zebrafish (Danio rerio) as a model species for 
aquatic ecotoxicology 
The zebrafish is a small (adult size 3-5 cm) freshwater cyprinid fish native to the 
Ganges and Brahmaputra river basins on the Indian subcontinent (Spence et al. 
2008). The natural habitats of the zebrafish are slow-moving streams and 
floodplains, where the fish spawn just before the rainy monsoon season (Spence 
et al. 2008). The zebrafish has become a popular model species in a wide range 
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of scientific fields, from the behavioral and pharmacological sciences to 
environmental toxicology (Dai et al. 2014). This owes to the fact that zebrafish 
readily reproduce under controlled laboratory settings. Zebrafish embryos have 
been used for more than 60 years within the context of teratogenic (i.e. 
developmental disruption) effects of chemicals (Jones & Huffman 1957). The 
eggs are completely transparent which allows inspection of embryo morphology 
and bodily functions (i.e. heart rate) by stereomicroscope.  
The zebrafish embryo has become an important model for toxicity testing, as 
it is generally not considered to be an animal model up until the point of feeding, 
thus not requiring ethical permission (Scholz et al. 2008; Strähle et al. 2012; 
Braunbeck et al. 2015). The embryo-larvae nevertheless represents an in vivo 
test system enabling metabolic, toxicodynamic and toxicokinetic assessment of 
xenobiotics (Kühnert et al. 2013; Vogs et al. 2019). The embryo normally 
develops to sexual maturity in a matter of months, allowing for 
multigenerational studies, including exploration of transgenerational epigenetic 
mechanisms (Blanc et al. 2019). The whole zebrafish genome has been 
sequenced and extensively annotated, and has a high resemblance to higher 
vertebrate models, including humans (Howe et al. 2013). The robust behavioral 
repertoire of both adult and larval zebrafish has also made them utilized in 
studies of neuroactive pharmaceuticals (Kalueff et al. 2016). The 
aforementioned characteristics promoted the use of zebrafish in the studies 
presented in this thesis.  
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The overarching aim of this thesis was to explore the outcomes of ozonation 
treatment of STP effluents with a special focus on pharmaceuticals, by 
combining chemical analysis with zebrafish in vivo testing. The thesis work was 
divided into three parts. Firstly, a Swedish STP (Knivsta municipal STP) with 
full-scale ozonation treatment was evaluated for biological effects on 
reproduction and behavior in adult zebrafish (Paper I). Thereafter, selected 
pharmaceuticals (i.e. diclofenac, carbamazepine, and oxazepam) detected in the 
Knivsta STP effluent were treated in a laboratory-scale ozonation reactor and 
tested for zebrafish embryotoxicity (Paper II). As a direct follow-up to Paper II, 
where it was discovered that carbamazepine embryotoxicity increased following 
ozonation, carbamazepine OBPs were isolated from the ozonated solution and 
tested individually and in a mixture in zebrafish embryos (Paper III). 
 
The thesis encompassed the following research questions: 
 
? How much will the implementation of a full-scale ozonation treatment 
step at Knivsta STP improve pharmaceutical removal efficiency? 
? Will the ozonation of the Knivsta STP effluent affect biological responses 
in exposed adult zebrafish? 
? How may ozonation modulate zebrafish embryotoxicity of the three 
common pharmaceutical micropollutants carbamazepine, diclofenac, and 
oxazepam? 
? Which OBPs are responsible for induced carbamazepine embryotoxicity 
following ozonation? 
? Are carbamazepine OBPs stable in water solution during storage for two 
weeks at laboratory conditions? 
 
 
2 Aims of the thesis 
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The following sections briefly summarize the study designs and provide 
rationales for endpoint selection of the different studies within the thesis. All 
experimentation on adult fish was approved beforehand by the Animal Ethics 
Committee in Gothenburg (DNR79-2014). 
3.1 Study designs 
The thesis work centered on two experimental settings; a full-scale ozonation 
pilot plant at Knivsta municipal STP, and a bench-scale laboratory ozonation 
reactor (Figure 1). 
 
Figure 1. Photographs showing the experimental settings in (A) Paper I (Knivsta municipal STP 
with full-scale ozonation plant, photographer: Berndt Björlenius) and (B) Papers II and III (Bench-
scale experimental ozonation reactor, photographer: Johannes Pohl). 
 
3 Materials and methods 
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3.1.1 Knivsta sewage treatment plant (Paper I) 
The first part of the thesis work (Paper I) aimed to evaluate in vivo endocrine, 
reproductive, and behavioral responses in zebrafish exposed to the ozonated 
Knivsta STP effluent at a full-scale experimental ozonation treatment facility. 
The ozonation removal efficiency of 105 pharmaceuticals in the treated effluent 
was also examined. The on-site study at Knivsta STP was conducted in 
November 2015. At the time Knivsta municipal STP had a treatment capacity of 
13 000 population equivalents (PE) at 300 m3 sewage per hour, with 
approximately 11 000 connected persons in 2015 (Roslagsvatten, 2016). The 
mean volume treated sewage in 2015 was 3708 m3 per day, and a maximum flow 
of 8600 m3 per day (Roslagsvatten, 2016). Mostly household spill water was 
treated at the STP, no major industries were connected at the time of the study 
(Roslagsvatten, 2016).  
Knivsta STP had five major treatment steps at the time of the ozonation 
project: pretreatment (3 mm bar distance screen), primary sedimentation with 
chemical precipitation, biological treatment (active sludge pools and nitrification 
reactors with aggregate), secondary sedimentation, and post-chemical 
precipitation (iron chloride PIX-111). The mean hydraulic retention time in 
Knivsta STP during the time of the study was 38 hours, producing an effluent 
with < 3 mg L-1 biological oxygen demand 7 days (BOD7), 9 mg L-1 total 
nitrogen, 0.11 mg L-1 total phosphorus, and 0.09 mg L-1 ammonia nitrogen. In 
2015, Knivsta STP effluent mean concentrations of cadmium, copper, and zink 
were 0.021, 1.6, and 15.7 μg L-1, respectively (Roslagsvatten, 2016). After 
treatment, the effluent was released into a constructed wetland polishing pond 
from where it discharged into the recipient stream, Knivstån.  
The ozonation step (7 mg L-1 ozone dose) was connected after the 
conventional treatment, which allowed parallel studies on ozonated- and 
nonozonated effluent (see detailed description of the ozonation plant in the 
materials and methods sections in Östman et al. (2019) and Paper I). Contact 
filters filled with expanded clay aggregates were installed after ozonation for 
reducing any remnant ozone. A mobile laboratory (isolated 10 ft ISO-container) 
containing aquariums (n = 3 per treatment, n = 10 fish, ~5 males and 5 females, 
per aquaria) for the fish studies was installed next to the ozonation plant. Water 
from effluent (pH: 7 ± 0.05, nitrate: 84 ± 4 mg L-1) ozonated effluent (pH: 7.5 ± 
0.02, nitrate: 101 ± 5 mg L-1), and carbon-filtered municipal tap water (pH: 7.5 
± 0.09, nitrate: < limit of measurement) was continuously pumped into 60 L 
polyethylene plastic barrels, warmed to 25 °C by immersion heaters, and 
distributed into aerated aquaria at a flow of 10 mL min-1 (Figure 2).  
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Figure 2. Experimental setting used in Paper I. Carbon-filtered water from the municipal tap water 
system, treated sewage effluent from the Knivsta STP, and ozonated effluent was continuously 
pumped into the aquariums (n = 3 per treatment) on-site.  
3.1.2 Bench-scale laboratory ozone reactor (Papers II and III) 
 
Figure 3. (A) Dissolved ozone concentration (mg L-1) in the ozonation reactor (0.25 L carbon 
filtered tap water at 25 °C) measured at 1, 5, 10, 30, 60, and 135 min after initiation of the ozonation 
process  (determined in Study II). (B) Table of ozone contact times and peak ozone concentrations 
in Papers II and III. 
An experimental bench-scale ozonation reactor was set up for the purpose to 
ozonate pharmaceuticals (Papers II and III). An ozone generator (Aqua Medic 
GMBH, Germany) supplying 100 mg O3 per hour was used to ozonate test 
24 
 
solutions (v = 0.25 L, 25 °C) by way of diffusion stone in Erlenmeyer flasks. All 
pharmaceuticals were mixed in carbon-filtered tap water which also constituted 
the negative control. A preliminary test of ozone concentrations in the reactor 
during continuous ozonation was performed to evaluate ozonation efficiency 
before commencing the studies presented in Paper II (Figure 3). Ozone 
concentrations were measured using the LCK310 Ozone cuvette test (0.05−2 mg 
L-1 O3 measurement range) in a DR 3900™ spectrophotometer (Hach, United 
States). The set up was localized to a fume hood in order to dissipate residual 
ozone gas.  
From the preliminary test, two ozone dosages were selected for the 
subsequent treatment of the tested pharmaceuticals in Paper II (Figure 4); 1 min 
ozonation (peak dissolved ozone concentration of 0.053 mg L-1), and 10 min 
ozonation (0.147 mg L-1). The rationale for choosing these two dosages was 
mainly due to practical feasibility. In order to complete ozonation and initiate 
the embryotoxicity experiments during the same morning, additional or longer 
ozonation dosages would not have been possible.  
 
Figure 4. Experimental setting used in Paper II. Three concentrations of each pharmaceutical were 
selected by preliminary toxicity screening and ozonated for 1 and 10 minutes.  
The last part of the thesis work (Paper III) aimed to further investigate individual 
carbamazepine OBPs isolated from ozonated solution (Figure 5). Zebrafish 
embryo assays were used to test the individual and mixture toxicity of the four  
carbamazepine OBPs 10,11-epoxide (CBZ-EP), 10,11-Dihydrocarbamazepine 
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(DI-CBZ), 1-(2-benzaldehyde)-4-hydro-(1H,3H)-quinazoline-2-one (BQM), 
and 1-(2-benzaldehyde)-(1H,3H)-quinazoline-2,4-dione (BQD).  
The test concentrations were selected based on quantified concentrations in 
ozonated CBZ. Three concentration levels were tested, corresponding with 
approximately 0.5×, 1×, and 2× the concentrations of each respective OBP. 
Since BQM and BQD were not commercially available they had to be extracted 
from ozonated carbamazepine. The isolated compounds were eluted in methanol 
(evaporated before addition of carbon-filtered tap water) and tested for 
embryotoxicity in the zebrafish embryo assay along with CBZ-EP and DI-CBZ 
which were prepared from analytical-grade powder in carbon-filtered tap water. 
 
Figure 5. Experimental setting used in Paper III. Four carbamazepine OBPs were tested in zebrafish 
embryo toxicity tests individually and in a mixture. The ozonated carbamazepine solution was 
stored in the dark at 22 °C for two weeks and repeatedly tested for embryotoxicity and OBP 
concentration after 1h, 1 week, and 2 week storage. 
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3.2 Adult zebrafish biological endpoints (Paper I) 
3.2.1 Reproduction 
Adult zebrafish were exposed to the Knivsta STP effluent pre- and postozonation 
for 21 days and tested for fecundity and behavioral effects (Figure 6). The 
reproductive status was evaluated by measuring fecundity (i.e. the number of 
spawned fertilized eggs per female per day). This method was selected as it has 
been utilized in earlier fecundity studies in zebrafish (Lister et al. 2009). 
Spawned eggs were collected from each aquarium after each ‘spawning trail’, 
counted, and assessed for fertilization success (i.e. if the egg had progressed 
beyond the 4-cell stage) once per day during the last 7 days of the 21-day 
exposure. The spawning trails began by moving the fish into metal mesh cages 
(5 mm mesh size) at 09:00 (when the aquarium lights were turned on) and 
allowing them 30 min to spawn. This method tend to stimulate zebrafish 
spawning. Each aquarium population, with five putative males and five putative 
females, was considered a replicate. 
At the termination of the 21 day exposure exposure, the fish were euthanized 
and prepared for histological sectioning of gonadal tissue. Fish were fixed in 
phosphate-buffered formaldehyde, embedded in paraffin blocks, and dehydrated 
before sectioned and stained with haematoxylin-eosin. Prepared sections were 
analyzed under stereo microscope. To confirm fecundity effects, the histological 
status of the ovaries (i.e. the proportion of primary, cortical alveolar, and mature 
vitellogenic oocytes) was investigated in female fish. Male gonadal tissues were 
assessed for semen content in seminiferous tubuli, and signs of intersex was also 
examined. 
 
Figure 6. Experimental timeline for the zebrafish study at Knivsta STP (Paper I). Fish were exposed 
over three weeks, where the last week consisted of a fecundity test, and the last day consisted of a 
behavior test. Embryos were collected from the first successful spawning in each aquarium and 
tested for embryotoxicity in a 6 day embryo toxicity test.  
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3.2.2 Gene expression analysis 
Zebrafish hepatic tissue was homogenized using a Precellys Evolution (Bertin 
instruments, France) system equipped 190 with liquid nitrogen cooling. RNA 
was then extracted using a QiaSymphony instrument with standard reagents 
(Qiagen, Germany). The RNA integrity and concentration were measured in a 
2100 Bioanalyzer system (Agilent Technologies, USA) to ensure sample 
template quality. Quantitative polymerase chain reaction (qPCR) was performed 
using a Rotor-Gene 3000 instrument (Corbett Research, Australia) with the one-
step KAPA SYBR® FAST one-step qPCR kit, according to the manufacturers 
recommended protocol. The primer sequences were synthesized, evaluated and 
the reaction products were sequenced to ensure product specificity. Relative 
mRNA expression was calculated by the method described by Livak and 
Schmittgen (2001). Three genes were selected for gene expression analysis: 
cyp1a1 (dioxin responsive gene), ERa, and vtg2 (xenoestrogenic responsive 
genes). These genes have been used as biomarkers in earlier studies on ozonated 
sewage effluents (Gunnarsson et al. 2009b; Beijer et al. 2017). 
3.2.3 Adult behavior 
The adult zebrafish behavior was tested in a novel tank test, meaning that fish 
were transferred individually together with 0.5 L aquarium water to unfamiliar 
non-transparent glass beakers (12 cm in diameter). After placement in the glass 
beakers, fish were filmed by an above-mounted video camera over 10 min. 
Locomotor activity was then tracked using Zebralab software (ViewPoint, 
France). A stressed zebrafish will freeze when introduced to a novel 
environment, before starting to investigate its surroundings (Demin et al. 2020). 
This metric for anxiety-like response was a simplified version of more refined 
methods, including time spent bottom-dwelling and response to visual or 
olfactory distress cues (Kalueff et al. 2013).  
3.3 Zebrafish embryo-larvae biological endpoints 
(Papers I-III) 
Fertilized zebrafish embryos were exposed individually in Parafilm M (Bemis 
Company, United States) 96-well plates for 144 hours post- fertilization (hpf). 
The method has been extensively used and characterized at the Department of 
Biomedical Sciences and Veterinary Public Health (BVF) aquatic facility were 
all studies took place (Carlsson, 2007; Carlsson et al. 2011; Carlsson & Norrgren 
2014). The zebrafish embryotoxicity assays were performed under controlled 
ambient conditions (12:12 h light cycle, 26 ± 1 °C air temperature).  
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Figure 7. Overview of the zebrafish embryotoxicity assay experimental timeline used in the thesis 
work. 
All exposures were static (i.e. exposure solutions were not changed during the 
tests). Heart rate at 48 hpf, time until hatching (h), swimming activity during 
alternating light/dark periods, and proportion of affected (dead and malformed) 
embryos at 144 hpf were the recorded endpoints (Figure 7). The embryos were 
assessed under stereo microscope for observable morphological deformities 
such as pericardial edema, yolk sac edema, and scoliosis.  
Heart rate was recorded while minimizing confounding factors. Each plate 
was measured over the course of about 45 minutes, under which time the 
measured air temperature did not fluctuate. The Parafilm M cover on the plates 
was not removed during heart rate measurements (inverted microscope was used 
in order to observe the plates from below). An external LED-light was used to 
illuminate the embryos at equal intensity to avoid temperature increase. The 
heart rate (heartbeats per minute, bpm) was then calculated by the formula  
?? ? ???????????????????????????? 
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The hatching time was recorded by photographing (Canon EOS 500D) the 96-
well plate(s) each hour between ~48 hpf and 144 hpf. A timed LED lighting 
system provided light during photography (switched on for 3 seconds) in the 
dark hours. The image files were manually inspected to deduce which hpf each 
larva hatched.  
The zebrafish larvae behavior in response to shifts in light intensity was 
measured using the Zebrabox tracking system and software (Viewpoint, France). 
The larvae locomotor activity has been recommended as a rapid and valuable 
test for neurodevelopmental effects in fish larvae (MacPhail et al. 2009). The 
behavioral phenotype (hypoactive or hyperactive) of each individual larvae was 
assessed by tracking the total locomotor activity (distance moved) during light 
and dark conditions. Only alive larvae without any observable malformations 
were included in order not to confound subsequent data analysis. The data was 
parsed, analyzed, and visualized using custom R software scripts (Pohl 2019). 
The embryotoxicity tests performed in Paper I using embryos and water from 
Knivsta STP were simplified as to only record incidence of affected 
(dead/malformed) embryo-larvae and locomotor activity during alternating light 
and dark periods. This method was used due to time and logistical constraints. 
Eggs from the first successful spawning from each aquarium were selected for 
assessment, and placed in 96-well plates together with treatment water from the 
respective aquarium. The exposure itself took place at the BVF aquatic facilities.  
Before commencing the ozonation tests in Paper II, concentration-response 
screenings for each of the selected pharmaceuticals (carbamazepine, diclofenac, 
and oxazepam) were performed. Three exposure concentrations (with effects 
ranging from none/weak in the lowest concentration to strong in the highest 
concentration), were identified and subsequently ozonated to evaluate how 
ozone would modulate their embryotoxicity. 
3.4 Chemical analysis 
Details on chemical analysis methodology and the OBP isolation protocol are 
found in the respective Materials & Method sections of Papers I-III. 
3.5 Statistics 
The R software (R Core Team, 2019), Rstudio interface (RStudio Team, 2019) 
and a collection of third-party packages (detailed in respective paper) were used 
for all statistical modeling, analysis, and plotting. Statistical methodology is 
elaborated upon in each respective paper. 
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The results from Papers I-III are presented and discussed in the following 
sections. Figure 8 summarizes the most important results gathered during the 
thesis work. 
4.1 Full-scale ozonation at Knivsta STP (Paper I) 
4.1.1 Presence of pharmaceuticals in effluent and ozonation removal 
efficiency 
Chemical analysis was performed to assess the ozone removal efficiencies of 
pharmaceuticals at Knivsta STP (Paper I). Chemical analysis of the Knivsta STP 
effluent showed that 24 out of 105 target pharmaceuticals could be detected. The 
sum concentration of quantified pharmaceuticals in the effluent was 6392 ng L-
1.  After ozonation, 11 pharmaceuticals remained with a sum concentration of 
1421 ng L-1 (77% average ozone removal efficiency on mass). Oxazepam was 
among the least efficiently removed APIs (42%) by the ozone treatment. Most 
other detected pharmaceuticals were removed to a higher extent, with the 
examples of diclofenac (99%) and carbamazepine (97%). A complete table 
containing ozone removal efficiencies of screened pharmaceuticals can be found 
in Table 1 in Paper I. The ozonation removal efficiency of the quantified 
pharmaceuticals reported in Paper I was in line, albeit a little bit lower compared 
with earlier studies on sewage ozonation (Lavén et al. 2009; Beijer et al. 2017). 
This may have been due to the ozone dosage not being adjusted for fluctuations 
in total organic carbon content in the effluent, leading to a lower ozone 
concentrations due to ozone scavenging. Subsequent biological treatment of 
sewage effluents resulting in lower levels of dissolved organic carbon has been 
shown to be important for efficient ozonation removal of pharmaceuticals and 
other micropollutants (Ekblad et al. 2019).  
4 Results and discussion 
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During the operation of the Knivsta full-scale ozonation plant, a pilot 
treatment system containing several additional sewage treatment technologies 
(e.g. GAC) was evaluated with the same effluent and ozonated effluent line 
(Östman et al. 2019). It was observed that the GAC filter was more efficient than 
ozonation for the removal of a list of antibiotic pharmaceuticals in the effluent 
(Östman et al. 2019). GAC filters could also work particularly well for the 
removal of OBPs (Schollée et al. 2018). In general, the addition of a post-
ozonation filter (e.g. sand filter or GAC) seem to efficiently reduce effluent 
toxicity due to OBP abatement (Prasse et al. 2015; Völker et al. 2019). The 
chemical analysis of the ozonated Knivsta STP effluent did however not screen 
for the formation of any transformation-products or pharmaceutical OBPs (the 
OBP route of investigation was continued in Papers II and III).  
Non-target chemical analysis is promising for detecting OBPs, but should be 
coupled with ecotoxicologal evaluations of ozonated effluent to limit the amount 
of data to be analyzed in the search for key toxicants (Nürenberg et al. 2019). In 
vitro effect-based studies have deduced that only 1-3% of toxicity following 
sewage effluent ozonation could be explained by the list of analyzed 
micropollutants (predominately pharmaceuticals), indicating significant toxic 
potencies of e.g. OBPs (Escher et al. 2013; Tang et al. 2013). There is a wealth 
of scientific literature reporting diverging biological outcomes in fish exposed 
to ozonated effluents, both beneficial and adverse (Table 1). The biological 
outcomes of ozonated Knivsta STP effluent in exposed zebrafish fell into two 
categories: ambiguous and potentially adverse (Figure 8).  
4.1.2 Zebrafish fecundity, gonadal histology, and estrogen-associated 
gene expression 
There were no mortalities observed among the exposed fish during exposure to 
the Knivsta STP effluent pre- or postozonation. The mean nitrate concentrations 
measured in the effluent water (84 ± 4 mg L-1) and ozonated effluent (101 ± 5 
mg L-1) were not so high as to be considered toxic to zebrafish (Learmonth & 
Carvalho 2015).  
 
 
 
Figure 8 (next page). Schematic flow-chart of the thesis work highlighting important findings. The 
outcomes from the zebrafish exposure studies have been color-coded according to the subjectively 
interpreted nature of the effect (i.e. beneficial, adverse, and ambiguous) or no effect. 
33 
 
 
34 
 
Reproductive success was significantly higher in fish exposed to the ozonated 
STP effluent compared to the tap water control and conventional STP effluent. 
The average number of spawned fertilized eggs per female was 77.5 ± 7.5 in the 
ozonated effluent treatment, approximately double compared with the STP 
effluent (38.5 ± 1.9) and tap water control (34.4 ± 13.8) treatment groups 
(ANOVA p = 0.0021).  
Table 1. Non-exhaustive selection of peer-reviewed articles reporting effects of ozonated effluents 
in fish, showcasing different outcomes due to ozonation. 
Species Life stage Endpoint Outcome 
following 
ozonation 
Interpretation 
of effect  
Reference 
Japanese medaka 
(Oryzias latipes) 
Embryo-
larvae 
Hatching success Decreased Adverse Cao et al. (2009) 
Mortality Increased Adverse 
Deformity Increased Adverse 
Hatching success Decreased Adverse Yan et al. (2014) 
Mortality Increased Adverse 
Deformity Increased Adverse 
Rainbow trout  
(Oncorhynchus 
mykiss) 
Embryo-
larvae 
Whole-body 
vitellogenin 
Reduced Beneficial Stalter et al. (2010) 
 Mortality Increased Adverse 
 Hatching success Returned to 
normal 
Beneficial Margot et al. (2013) 
 Mortality Returned to 
normal 
Beneficial  
Zebrafish 
(Danio rerio) 
Adult Reproduction Increased Ambiguous Pohl et al. (2018) 
 Behavior Induced stress Adverse  
 Mortality Increased Adverse da Costa et al. (2014) 
Embryo-
larvae 
Hatching success Returned to 
normal 
Beneficial Lundström et al. (2010) 
Histological sections of female fish ovaries revealed that female fish exposed to 
the ozonated sewage effluent contained a two-fold higher proportion vitellogenic 
(i.e. mature) oocytes compared with the tap water control group (p = 0.0424). 
The histological assessment thus corroborated the results on egg production 
output in the fish. Further, histological evaluation of the male gonads in Paper I 
revealed no signs of intersex in any individual, and all males had normal 
seminiferous tubules with similar quantities of spermatozoa.  
Whether the induced reproductive output should be considered beneficial or 
adverse for fish fitness in the environment is highly speculative, and may 
therefore be considered an ambiguous outcome. The increased fecundity could 
potentially be associated with the increased estrogenicity of the post-ozonated 
effluent, as observed in the induced male hepatic vitellogenin gene expression. 
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Induced male hepatic vitellogenin should not be indicative of reproductive 
dysfunction per se. There have been reports of either no detrimental effects of 
vitellogenin-induced males on reproductive success in fish (Mills et al. 2003; 
Filby et al. 2010) or even stimulated reproductive output in P. promelas exposed 
to low concentrations (1 ng L-1) of EE2 (Jobling et al. 2003). A prolonged 
exposure to xenoestrogens in situ, however, may lead to intersex and 
reproductive disorder and be detrimental to fish populations (Kidd et al. 2007).  
Hepatic vitellogenin gene expression was induced in male fish, which might 
indicate that the chemical composition of the effluent became more estrogenic 
due to OBP formation. This consequence has also been illustrated in earlier 
studies of an ozonated hospital effluent (Maletz et al. 2013) and E2 (Bila et al. 
2007). The vitellogenin induction was, however, an unexpected result in light of 
previous studies showing the opposite – reduced vitellogenic responses in post-
ozonated STP effluent as compared to the untreated effluent (Gunnarsson et al. 
2009b; Stalter et al. 2010; Cuklev et al. 2012). 
Another explanation for the increased fecundity could be that the ozonated 
STP effluent represented an optimal breeding environment for the fish compared 
to the effluent and tap water. An early study on different sewage effluent 
disinfectant technologies and the effects of treated effluents in fathead minnow 
(Pimephales promelas) reported highly successful reproduction in the ozonated 
effluent, attributed to an optimal breeding environment for the fish (Ward & 
DeGraeve 1978).  
4.1.3 Zebrafish embryo-larvae developmental and behavioral 
responses 
No significant alterations of the analyzed zebrafish embryo-larvae endpoints 
(proportion dead and malformed embryos and larval locomotor activity) 
between the treatments were detected. Previous studies of an ozonated 
membrane-filtered sewage effluent have reported adverse effects in rainbow 
trout (Oncorhynchus mykiss) embryo-larvae, presumably by transformation 
product formation (Stalter et al. 2010). Newly fertilized Japanese medaka 
(Oryzias latipes) embryos exposed to sewage collected from a Chinese STP 
ozonated in a laboratory setting displayed affected hatching rate and incidence 
of death and malformations in ozone concentration-response manner (Cao et al. 
2009). Likewise, Yan et al. (2014) observed increasing embryo mortality and 
larval deformity in O. latipes exposed to ozonated sewage, due to aldehydic 
compound build-up from ozonation. Sewage ozonation has, on the other hand, 
also alleviated adverse effects from exposure to the non-ozonated sewage in fish 
embryo-larvae (Lundström et al. 2010; Margot et al. 2013; Sun et al. 2017). 
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4.1.4 Adult zebrafish behavioral response 
The behavioral assay was performed on the final day of the 21-day exposure. 
Directly after transfer from its home aquarium to a novel tank, each zebrafish 
was recorded by an above-mounted video camera for 10 minutes. Fish exposed 
to the ozonated STP effluent exhibited a significantly lower swimming activity 
during the first minute of the swimming activity test as compared with tap water 
control exposed individuals (ANOVA p < 0.0001). Thus, the less active fish 
exhibited a more pronounced ‘freezing’ behavior when introduced to a novel, 
unknown environment. No difference in swimming activity between the control 
and the non-ozonated effluent treatment group was detected. This result could 
indicate a stress-related behavioral phenotype in the fish exposed to the ozonated 
effluent. Reduced swimming activity in fish suddenly put into a novel 
environment (i.e. aquarium) may be interpreted as a stress response (Kalueff et 
al. 2013).  
Stress is an important factor for survival in hostile settings, but chronic stress 
may produce subsequent adverse effects (Wendelaar Bonga 1997). Stressed fish 
exhibit induced levels of the hormone serotonin (Winberg et al. 1992). Serotonin 
modulates the hypothalamus-pituitary-interrenal axis in fish. Furthermore, it 
also stimulates the reproductive neuroendocrine axis in fish by increasing the 
release of gonadotropins from the pituitary gland, which controls gonad 
maturation and egg release (Prasad et al. 2015). Whether endocrine disruption 
of the serotonergic system was influencing the observed fecundity and stress 
effects in Paper I remains speculative. However, recent experimental evidence 
supports the notion that STP effluent ozonation may induce brain serotonin 
concentrations in exposed fish (Maya et al. 2018). Whether these effects would 
cause adverse impacts in wild fish populations is difficult to predict. It should 
also be reiterated that the reproductive and behavioral effects on adult zebrafish 
in Paper I was observed at 100% effluent concentration. In the environment, 
effluents are diluted in the recipient stream leading to lower concentrations of 
micropollutants.  
4.2 Bench-scale ozonation of carbamazepine, 
diclofenac, and oxazepam (Paper II) 
The second part of the thesis work (Paper II) aimed to test embryotoxicity 
outcomes of ozone treatment of individual pharmaceuticals in a controlled 
laboratory setting. The biological outcomes of the study presented in Paper I 
were resulting from exposure to a mixture of at least 24 ozonated APIs. Three 
of these, carbamazepine, diclofenac, and oxazepam were selected for testing in 
Paper II. These particular pharmaceuticals were chosen because they cover three 
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different classes of drugs (i.e. an anticonvulsant drug, a nonsteroidal anti-
inflammatory drug (NSAID), and a benzodiazepine) with different modes of 
action and biological targets. Furthermore, they exemplified pharmaceuticals 
both degradable (carbamazepine and diclofenac) and not easily degradable by 
ozonation (oxazepam) in the STP effluent ozonation study (Paper I). 
Paper II combined the embryotoxicity effect screenings with chemical 
screenings. The chemical screenings were performed to elucidate ozone removal 
efficiencies of the pharmaceuticals in the bench ozonation set-up, as well as 
investigate the formation of four putative carbamazepine OBPs. Ozonated tap 
water was also tested in each of the three pharmaceutical ozonation studies. No 
adverse biological responses were detected, indicating that residual ozone did 
not cause toxicity in the experimental setup.   
4.2.1 Ozonation removal efficiencies  
Ozonation for 1 min removed 20 ± 3.4% carbamazepine, 25 ± 16% diclofenac, 
and 2.0 ± 4.4% oxazepam. Increasing ozone dosage time improved removal of 
the parent compound in all three tested pharmaceuticals. Ozonation for 10 min 
removed 90 ± 11% carbamazepine, 97 ± 3.8% diclofenac, and 19 ± 5.7% 
oxazepam. These results are comparable to the ozone removal efficiencies 
reported in Paper I, suggesting that the experimental ozonation setup in Paper II 
served as a reasonable model of a large ozonation facility. 
Chemical analysis revealed a discrepancy between nominal and measured 
concentrations of carbamazepine and oxazepam. The nominal concentrations 
corresponded with the measured concentrations on average by 59% for 
carbamazepine and 81% for oxazepam. These deviations were probably due to 
issues of solubility and precipitation in water for carbamazepine and Dimethyl 
sulfoxide (DMSO) for oxazepam. Measured concentrations of diclofenac were 
in good agreement with nominal concentrations. 
4.2.2 Diclofenac 
Diclofenac is a nonsteroidal anti-inflammatory drug used for the treatment of 
inflammation and related pain. Exposure at medium (7.4 mg L-1) and high (15 
mg L-1) diclofenac concentrations caused pericardial- and yolk-sac edemas, as 
well as absent systemic circulation, at 48 hpf. The highest concentration (15 mg 
L-1) exposure also caused a reduced heart rate by ~50%. Subsequently, this 
treatment group exhibited 100% mortalities at 144 hpf. Hatching time was not 
affected in any treatment group, however embryos in treated in the highest 
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concentration all died before hatching. No behavioral effects in any treatment 
group were detected for diclofenac in the locomotor activity assay. 
Diclofenac toxicity was completely abolished after ozonation. The 
proportion affected individuals (81%) exposed to the lowest diclofenac 
concentration at 144 hpf, was reduced to the control group level after 1 min 
ozonation. Diclofenac ozonated for 10 min did not produce any toxicity in any 
endpoint. A Microtox (Vibrio fischeri NRRL B-11177 strain) in vitro study has 
previously indicated a reduction in diclofenac toxicity following ozonation, not 
unlike the outcome presented in Paper II (Coelho et al. 2009). There are, 
however, to our current knowledge no previously published studies on fish 
embryotoxicity of ozonated diclofenac. Diclofenac ozonation did not form toxic 
OBP, based on the results from Paper II. 
4.2.3 Oxazepam 
Oxazepam is an anxiolytic psychoactive drug used to treat anxiety disorders. No 
alterations in zebrafish lethal or sublethal endpoints were detected in any 
treatment group, either pre- or post ozonation. The larvae locomotor activity 
screening did not give rise to any deviations in behavior between the different 
concentrations. However, ozonation of the highest ozone concentration for 10 
min (reducing the oxazepam concentration from 7 to 6.1 mg L-1) caused 
hypoactivity during dark conditions.  
Oxazepam is known to produce behavioral effects (increased boldness) in 
adult wild European perch at a concentration of 910 μg L-1 (Brodin et al. 2013). 
Embryonal life stages of fish however seem to be less sensitive to oxazepam 
exposure than adult fish. A reduced swimming activity during dark periods has 
been recorded previously in larval O. latipes exposed to 10 mg L-1 oxazepam 
(Chiffre et al. 2016). Oxazepam is a GABAA receptor activator, an anxiolytic 
benzodiazepine which gives rise to GABAergic behavioral modifications. Since 
larvae activity is induced by dark periods (an anxiety-like response) in the larvae 
swimming activity assay, the hypoactivity illustrated in Paper II and other 
studies may thusly be explained by an anxiolytic mode of action. One possibility 
of this response could be the formation of OBPs potentiating the anxiolytic 
properties of oxazepam in the exposed zebrafish embryos. The results of Paper 
II thusly indicated that ozonation of oxazepam may increase its anxiolytic 
properties, which may lead to effects on subsequent survivability. 
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4.2.4 Carbamazepine 
Carbamazepine is a drug used for the treatment of epilepsy and related 
symptoms. Carbamazepine exposure resulted in embryotoxicity at 144 hpf in the 
medium (30 mg L-1) and highest (50 mg L-1) treatment groups with 88% and 
100% affected individuals respectively, mostly due to occurrence of pericardial 
edema. Carbamazepine also significantly reduced the heart rate at 48 hpf in the 
highest treatment group (50 mg L-1), and all individuals in this group were dead 
before hatching. The pre-hatching mortalities were preceded by the incidence of 
pericardial and yolk-sac edemas recorded at 48 hpf. The locomotor activity assay 
at 144 hpf did not show any significant effects on larvae behaviors in surviving 
unaffected larvae exposed to any treatment. Previous studies on zebrafish 
embryotoxicity of carbamazepine have reported results in line with Paper II. 
Beker van Woudenberg et al. (2014) reported that the most sensitive endpoint 
observed in zebrafish embryos exposed to carbamazepine was a delayed onset 
of hatching (72 hpf, EC50: 45.5 mg L-1) and pericardial edema (96 hpf, EC50: 52 
mg L-1). Besides embryotoxicity in zebrafish, carbamazepine (100 μg L-1) has 
also been shown to cause reproductive toxicity in adult Chinese rare minnows 
Gobiocypris rarus (Yan et al. 2018). Since carbamazepine is a highly persistent 
pharmaceutical in the aquatic environment, its removal from STP effluents 
should be considered a priority (Björlenius et al. 2018). However, as became 
evident in Paper II, ozonation may be an unsuitable option for carbamazepine 
abatement. 
Ozonation of carbamazepine increased the toxicity in all endpoints. The 
lowest observed effect concentration (LOEC) of carbamazepine based on 
proportion affected (dead and malformed) embryos was reduced from the 
medium (30 mg L-1) to the lowest (17 mg L-1) concentration following ozonation 
for 10 min. The heart rate and hatching time followed the same pattern of 
increased toxicity after 10 min carbamazepine ozonation. Increased 
carbamazepine toxicity post-ozonation has been illustrated in earlier in vitro 
cell-based studies (Dwivedi et al. 2018; Han et al. 2018) and a macroinvertebrate 
study (Heye et al. 2016).  
Since carbamazepine ozonation caused increasing embryotoxicity, four 
putative transformation products were included in the chemical analysis in Paper 
II. The rationale for measuring these specific compounds was that analytical 
standards were commercially available. Two of the OBPs, CBZ-EP and DI-
CBZ, increased in concentration with increasing ozonation dosing. CBZ-EP was 
detected in all ozonated carbamazepine samples, formed increasingly in relation 
to increasing ozone dosage. CBZ-EP is the main therapeutically active 
metabolite of carbamazepine formed by hepatic cytochrome p450 (Breton et al. 
2005). Based on the results in Paper II, it can also formed by ozonation. In a 
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previous study comparing the toxicity of carbamazepine and CBZ-EP in exposed 
macroinvertebrate (Chironomus riparius), CBZ-EP was found to be more than 
five times more toxic (Heye et al. 2016). Research has indicated how 
carbamazepine is biotransformed to CBZ-EP in fish, illustrating the concern of 
potential biological effects occurring in non-target species (Valdés et al. 2016). 
The second most detected carbamazepine OBP in Paper II was DI-CBZ. All 
carbamazepine treatment solutions, ozonated and not ozonated, contained 
concentrations of DI-CBZ exceeding LOQ. This may indicate that DI-CBZ was 
present as a contaminant in the carbamazepine analytical standard (manufacturer 
reported purity ≥ 98%). The quantified concentrations did however increase with 
increasing ozone dose, indicating that it was indeed formed by ozonation.  
The highest concentration among the screened OBPs was for CBZ-EP, with 
3.5 mg L-1 in the highest carbamazepine solution ozonated 10 minutes. DI-CBZ 
was the second most formed OBP, with a maximum concentration at 0.27 mg  
L-1. CBZ-EP and DI-CBZ were tested for embryotoxicity in Paper III along with 
two other carbamazepine OBPs inferred from literature, 1-(2-benzaldehyde)-4-
hydro-(1H,3H)-quinazoline-2-one (BQM), and 1-(2-benzaldehyde)-(1H,3H)-
quinazoline-2,4-dione (BQD). 
4.3 Embryotoxicity and stability of carbamazepine OBPs 
(Paper III) 
Since carbamazepine embryotoxicity was induced following ozonation in Paper 
II, the thesis work progressed by testing individual carbamazepine OBPs 
separately and in a mixture. Four OBPs were selected based on information from 
chemical screening in Paper II (CBZ-EP and DI-CBZ) and in the literature 
(BQM and BQD; McDowell et al. (2005)). Ozonation of 17.5 mg L-1 
carbamazepine for 10 minutes (0.29 mg L-1 peak dissolved O3 concentration) 
produced 0.5 mg L-1 CBZ-EP, 0.02 mg L-1 DI-CBZ, 2.2 mg L-1 BQM and 5.5 mg 
L-1 BQD. The CBZ-EP concentration corresponded well to the quantified 
concentration in Paper II (0.5 mg L-1). DI-CBZ was however quantified at a 
lower concentration (0.02 mg L-1) compared with results obtained in Paper II 
(0.2 mg L-1). A higher ozone dosage, due to the use of a higher capacity oxygen 
injection apparatus, may explain this discrepancy (~0.15 mg L-1 in Paper II, ~0.3 
mg L-1 in Paper III). Chemical analysis of the pre-ozonated carbamazepine 
solution detected 0.04 mg L-1 DI-CBZ. Presence of DI-CBZ in the pre-ozonated 
carbamazepine was, as previously mentioned, also observed in Paper II. 
Three embryotoxicity endpoints (proportion of affected embryos (dead and 
malformed) at 144 hpf, heart rate, and time until hatching) were screened in the 
zebrafish embryo toxicity test assays. CBZ-EP (0.8–2.6 mg L-1) and DI-CBZ 
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(0.1–0.4 mg L-1) exposure did not cause embryotoxicity at the tested 
concentrations. The concentration-ranges were based on the chemical analysis 
in Paper II, where 0.5 mg L-1 CBZ-EP and 0.2 mg L-1 DI-CBZ were quantified 
in ozonated carbamazepine. Three nominal concentrations corresponding to half 
(0.5×), equal (1×), and twice (2×) that of the previously quantified 
concentrations were used. It was consequently deducted that CBZ-EP and DI-
CBZ formation were not the reasons for induced embryotoxicity following 
carbamazepine ozonation.  
The focus then shifted to BQM and BQD. Once again, three nominal 
concentrations based on the quantified concentrations following ozonation 
(0.5×, 1×, and 2×) were used as treatments for each compound. The 1× 
treatments (BQD: 1.9 mg L-1, BQM: 1.8 mg L-1) and 2× treatments (BQD: 6 mg 
L-1, BQM: 3.5 mg L-1) caused reduced heart-rate and prolonged hatching time, 
thus explaining these responses in embryos exposed to ozonated carbamazepine. 
The 2× concentrations induced ozonated carbamazepine-like malformations in 
the embryos (lack of swim bladder inflation and pericardial- and yolk sac 
edemas), while the 0.5x and 1x treatments did not.           
A mixture was prepared and tested for embryotoxicity in order to examine 
the joint effect of the four quantified carbamazepine OBPs. The mixture was 
designed to contain concentrations of each OBP relative to its respective 
concentration formed in ozonated carbamazepine in Paper II (regarding CBZ-
EP and DI-CBZ) and Paper III (regarding BQD and BQM). Three mixture 
concentrations were tested. The lowest concentration 0.5× (CBZ-EP: 0.7 mg      
L-1, DI-CBZ: 0.1 mg L-1, BQD: 1.5 mg L-1, BQM: 0.8 mg L-1) did not cause any 
embryotoxic responses in any of the three tested endpoints. The 1× concentration 
(CBZ-EP: 1.9 mg L-1, DI-CBZ: 0.2 mg L-1, BQD: 2.6 mg L-1, BQM: 1.6 mg L-
1) caused significant induction of affected (dead and malformed) embryos. A 
majority of the affected embryos displayed similar malformation types as those 
exposed to ozonated carbamazepine in Paper II (i.e. pericardial edema and/or 
lack of swim-bladder inflation). The highest mixture concentration 2× (CBZ-EP: 
4.3 mg L-1, DI-CBZ: 0.5 mg L-1, BQD: 7.7 mg L-1, BQM: 3.7 mg L-1) caused 
100% embryo mortalities before 24 hpf. Heart-rate was not affected in the 0.5× 
treatment. Meanwhile, the 1× treatment group exhibited a reduced heart-rate, 
similar to embryos exposed to ozonated CBZ in Paper II. The hatching time was 
however not affected by any mixture treatment.  
In order to test the stability of the carbamazepine OBPs, the solutions were 
stored under laboratory conditions (22 °C) for two weeks during which time the 
concentrations were measured. Furthermore, the embryotoxicity of ozonated 
carbamazepine was tested repeatedly over a two-week storage of the test solution 
(testing after 0 h, 1 h, 24 h, 1 week, and 2 weeks of storage). This was done to 
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determine the stability of the OBPs in the experimental water and if the 
embryotoxicity induced after ozonation of carbamazepine persists even after 
prolonged storage, and consequently indicate that the OBPs formed could be 
persistent in the environment. All analyzed OBPs remained at stable 
concentrations during the two-week storage period except BQD, which declined 
by 94%. Meanwhile, embryotoxicity remained in all tested storage time points, 
decreasing from ~95% directly after ozonation to ~75% after two week storage. 
Since BQM and BQD have previously been detected in an ozonated effluent 
(McDowell et al. 2005), the toxic and persistence properties of BQM should be 
viewed as potentially problematic and in need of further investigation.    
4.4 General discussion 
As presented within this thesis, ozonation of effluents and pharmaceuticals 
can lead to the formation of toxic OBPs with potentially adverse effects in fish. 
In order to utilize ozonation to improve pharmaceutical residue elimination 
without risking increased toxicity, the method must be designed and operated 
with caution. Toxic OBPs need to be controlled for when applying ozonation as 
an additional treatment step at STPs. The OBPs, and their (eco)toxic effects, can 
often be removed from post-ozonated effluent by application of post-treatment 
filters (von Gunten, 2018; Völker et al. 2019). Formation of BQM and BQD 
from carbamazepine, which was determined to be the driver of post-ozonation 
toxicity induction in Paper III, has also been shown to be prevented by applying 
zeolite catalysts in the ozonation process (Rosal et al. 2008; Saeid et al. 2020). 
Further, experimental data has shown that a filter system (e.g. GAC) alone can 
be as effective as ozonation for removal of micropollutants including 
pharmaceuticals, but may be more expensive for full-scale implementation 
(Baresel et al. 2017).  
An important question regarding additional sewage effluent treatment 
technologies is indeed their monetary and environmental costs. The energy 
required for advanced treatment technologies could lead to increased carbon 
dioxide emissions, but ozonation seems to be favorable in terms of carbon 
footprint compared with carbon filter systems (Baresel et al. 2017). Ozonation 
as a sewage treatment technology has also been problematized in the context of 
human health, since the air pollution resulting from ozonation may potentially 
counteract the projected positive impacts on water quality (Papa et al. 2013). 
The beneficial aspects of ozonation should, however, continue to increase as 
technological developments will improve energy efficiency (Papa et al. 2013). 
It must also be mentioned that the issue of pharmaceutical pollution in the 
aquatic environment may not just be tackled by end-of-pipe approaches such as 
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ozonation. Upstream actions, meaning mitigation measures such as overhauling 
prescription practices or implement urine separating toilets, could also be part of 
the solution (Blair, 2016). 
In the Knivsta STP effluent (Paper I), carbamazepine was detected at a 
concentration of 0.2 μg L-1, which would lead to a theoretical BQM 
concentration of 0.08 μg L-1 and a BQD concentration of 0.02 μg L-1 post 
ozonation (based on calculated yields using the ozonation method in Paper III). 
Whether these concentrations would constitute a risk to the aquatic environment 
is not clear, however these concentrations are ~ 90 000 lower than the lowest 
observed effect concentrations in Paper III. This may demonstrate a limited risk 
to developing zebrafish embryos. However, aspects of bioaccumulative 
properties and long-term environmental effects, which are highly relevant since 
BQM seem to have persistent properties, is yet to be uncovered. Environmental 
monitoring and (eco)toxicity assessment of OBPs and other metabolic or 
biotransformation metabolites are challenging endeavors since these compounds 
rarely have commercially available analytical standards (Lee & Gunten, 2016). 
As such, in silico modeling of toxicophores (i.e. chemical structures with 
predicted toxic potency) arising post-ozonation has been emphasized as a useful 
method for ‘flagging’ potentially toxic OBPs (Escher & Fenner, 2011). Still, 
whole organism in vivo toxicity assessment will continue to be important to 
verify predicted toxic potencies of pharmaceutical OBPs. 
The thesis work primarily used the zebrafish embryo model as a whole-
organism in vivo model, which allowed rapid and data-rich testing of ozonated 
pharmaceuticals and isolated OBPs using a limited volume of test solution. The 
suitability and environmental relevance of the zebrafish embryo should however 
be objectively highlighted at this point. For instance, the metabolic activation of 
the tested chemicals may be lower in the embryo compared with the adult fish, 
thus leading to weaker sensitivity in zebrafish embryo tests (Klüver et al. 2011; 
Knöbel et al. 2012). Other factors such as the physiochemical properties of the 
tested compound may affect uptake in the embryonal life-stage, leading e.g. to 
lower internal concentrations in the embryos as compared with adult fish (Klüver 
et al. 2015). Still, the fish embryo toxicity in vivo model has been shown to 
accurately predict toxicity in adult fish for a multitude of micropollutants with 
different modes of action, indicating that it is a relevant model for (eco)toxicity 
hazard assessments (Belanger et al. 2013)  In conclusion, it might not be prudent 
to directly extrapolate the results of the thesis work (Paper II and III) to the 
ecosystem level, as the embryotoxicity tests indicated adverse effects of the 
tested pharmaceuticals and OBPs at 1000−100 000 times the concentrations 
detected in the aquatic environment. Despite their relative lack of sensitivity, 
however, the embryotoxicity tests provided valuable information on the 
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diverging toxic outcomes following the ozonation of pharmaceuticals due to 
OBP formation. 
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This thesis has investigated the chemical and biological outcomes of 
ozonation in the context of pharmaceuticals in STP effluents. While chemical 
analysis revealed enhanced removal efficiencies of several pharmaceuticals, 
biological responses in zebrafish also became induced, illuminating the 
complexity of ozonation as an advanced sewage treatment technology. In Paper 
I, ozonation of the STP effluent removed 77% of the measured pharmaceuticals. 
The ozone-treated effluent did however give rise to unexpected potentially 
adverse effects such as induced vitellogenin gene expression in male fish, and 
an anxiety-like stress response in these fish was observed. These biological 
responses may possibly indicate effects due to OBP formation.  Further, 
fecundity was 2-fold higher in fish exposed to the ozonated effluent compared 
to the non-ozonated effluent and the tap water control group.  
Whether the increased fecundity constituted an adverse or beneficial outcome 
remains speculative. Diverging zebrafish embryotoxicity outcomes were then 
observed following ozonation of carbamazepine, diclofenac, and oxazepam in a 
bench-scale laboratory ozonation reactor (Paper II). While diclofenac 
embryotoxicity was eliminated, carbamazepine and oxazepam showed induced 
embryotoxic effects following ozonation. Carbamazepine OBPs were then 
isolated and tested for embryotoxicity individually and in mixture (Paper III). 
The study revealed the drivers of carbamazepine post-ozonation embryotoxicity 
as being BQM and BQD, thus directly associating OBPs to adverse biological 
effects of pharmaceutical ozonation. Besides, BQM was shown to be persistent 
over a two-week stability test under laboratory conditions, indicating that 
carbamazepine OBPs could be environmentally relevant toxic compounds 
needing attention. Efficient formation prevention and removal of OBPs from 
ozonated sewage effluents should ultimately be ensured in order to avert 
potentially increasing environmental risks.  
 
 
5 Conclusions 
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There are considerable knowledge gaps regarding the environmental effects and 
fate of pharmaceutical OBPs and other transformation products originating from 
water treatment. Future work on this issue requires an integrated 
multidisciplinary approach combining methods from analytical chemistry and 
ecotoxicology, as has been utilized in this thesis. 
 
? Future efforts should proceed to gather mechanistic data of OBPs, in order 
to explain how ozone-mediated oxidation of micropollutants increase 
toxicity.  
? Bioconcentration factors and bioaccumulative properties of potentially 
problematic OBPs (e.g. BQM) should be investigated    
? Long term exposure and multigenerational testing at environmentally 
relevant concentrations could add valuable information on the potential 
environmental risks of OBPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Future perspectives 
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Most people are aware that old, unused, medicine should be returned to the 
pharmacy, not sent down the toilet. Still, about half of all medicine we consume 
goes right into the aquatic environment through the sewage. It happens since the 
body excretes pharmaceutical residues in urine and feces after treatment. The 
sewage treatment plants cannot efficiently remove pharmaceutical residues from 
sewage water. Therefore we may count on that residues of all pharmaceuticals 
human and animals consumes ultimately reaches the aquatic environment. 
Pharmaceuticals can affect aquatic organisms since they share many if not most 
of the biological receptors that the pharmaceuticals interact with. For example, 
anti-anxiety medication can make perch less intimidated by their predators, and 
contraceptive pills can cause male fish to reverse sex and produce eggs in their 
testis.  
Improvement of sewage treatment has been urged, since it has been shown 
that pharmaceuticals can affect fish and other aquatic organisms. Ozonation of 
sewage water could be a method to prevent pharmaceutical pollution in the 
environment. Ozone is a powerful gaseous oxidant which attacks the 
pharmaceutical molecule and degrades it. In 2014, a full-scale ozonation step 
was constructed at the Knivsta municipal sewage treatment plant in Sweden in 
order to study the removal efficiency of pharmaceuticals. Out of 105 
pharmaceuticals screened for, 24 could be found in the sewage effluent before 
ozonation. Ozonation reduced the concentrations of these by 77%. Meanwhile, 
the biological effects of the sewage water before and after ozonation was studied 
in fish (zebrafish, Danio rerio). The fish were divided into three experimental 
groups during the three-week study. It was shown that fish in the ozonated 
sewage water spawned twice as many eggs as in the two other groups. Whether 
this outcome meant that the fish fared better or worse than the other groups us 
difficult to determine. The male fish in the ozonated sewage group also displayed 
an upregulated expression of an estrogen-sensitive gene which indicated that 
ozonation may have created more estrogenic-like chemicals in the sewage water. 
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The behavior of the fish in the ozonated sewage effluent was also affected. Fish 
tended to be more stressed by being separated from their home aquaria at the end 
of the study. These results may point to that ozonation can change the chemical 
composition of sewage water, and thereby affect fish in new ways. 
Ozone hardly ever breaks down pharmaceuticals completely, and it has been 
shown that ozonation can form so-called byproducts. How toxic these 
compounds are is largely unknown. That is why the three common 
pharmaceuticals diclofenac, carbamazepine, and oxazepam were studied 
regarding how ozone would affect their toxicity in zebrafish embryos. It was 
shown that diclofenac and carbamazepine were removed by more than 90% from 
water solution after ozonation, while oxazepam was less easily broken down 
(20%). Diclofenac ozonation also effectively removed its toxicity. On the flip 
side, the toxicity of carbamazepine and oxazepam increased, which was 
surprising and a bit concerning. Carbamazepine byproducts have identified 
earlier, and with the help of this information we could isolate and test four 
different carbamazepine byproducts. This enabled an additional study on 
zebrafish embryos where we for the first time could prove that two compounds, 
BQM and BQD, were responsible for the increased toxicity of carbamazepine 
following ozonation. 
Ozonation of pharmaceuticals can create toxic byproducts, which is 
problematic. We should avoid creating more damage than good when we 
improve the treatment of sewage water. Fortunately, it seems that byproducts 
can be broken down by microorganisms in filters that the sewage water can pass 
after ozone treatment. Some add-ons to the ozonation process, such as catalysts, 
can prevent the creation of byproducts. The problem of pharmaceutical residues 
in the environment will however probably need more types of solutions. For 
instance, the development of new drugs that more easily breaks down into non-
toxic byproducts in sewage, or collection and separate treatment of urine in 
toilets. The research aiming for a cleaner aquatic environment, free from 
pharmaceuticals, continues.                   
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De flesta känner till att gamla oanvända mediciner ska skickas tillbaka till 
apoteket, inte ner i toaletten. Ändå går i princip hälften av alla läkemedel vi äter 
rakt ut i vattenmiljön via avloppet. Det sker eftersom kroppen utsöndrar resterna 
av läkemedlen genom urin och avföring efter behandling. Avloppsreningsverken 
kan i dagsläget inte effektivt rena bort läkemedelsrester från avloppsvattnet. 
Därför kan vi räkna med att spår av all medicin som både människor och djur 
äter till sist når vattenmiljön. Läkemedel kan påverka vattenlevande organismer 
som i stort delar de biologiska receptorer som läkemedlen verkar på. Till 
exempel kan ångestdämpande mediciner göra abborrar mindre rädda för de 
rovdjur som jagar dem, och östrogena p-piller kan orsaka att hanliga fiskar byter 
kön och börjar bilda ägg i testiklarna.  
Då man har sett att läkemedel kan påverka fiskar och andra vattenlevande 
djur vill man förbättra reningen. Ozonering av avloppsvatten skulle kunna bli ett 
sätt att förebygga läkemedel i miljön. Ozon, en kraftfull oxidant i gasform, 
angriper läkemedelsmolekylen och bryter ned den. Vid Knivsta reningsverk 
byggdes 2014 en ozoneringsanläggning i full skala för att testa hur mycket av 
läkemedlen i avloppsvattnet som kunde brytas ned. Av 105 uppmätta läkemedel 
kunde 24 upptäckas i avloppet. Ozoneringen reducerade koncentrationerna av 
dessa med 77 %. Under tiden undersöktes effekterna av avloppsvattnet före och 
efter ozonering på fisk (sebrafisk, Danio rerio). Fiskarna delades in i tre 
försöksgrupper under försöket som varade i tre veckor. En i vanligt 
avloppsvatten, en i ozonerat avloppsvatten och en kontrollgrupp i vanligt 
kranvatten. Det visade sig att fiskarna i det ozonerade avloppsvattnet lekte bättre, 
och producerade dubbelt så många ägg än fiskarna i de två andra grupperna. Om 
det berodde på att fiskarna i det ozonerade avloppsvattnet mådde bättre än de 
andra grupperna eller sämre är dock svårt att avgöra. De hanliga fiskarna från 
gruppen i det ozonerade avloppsvattnet uppvisade även ett ökat genuttryck av 
en östrogen-känslig gen vilket indikerade att ozoneringen kan ha bildat fler 
östrogen-lika ämnen i avloppsvattnet.  Vidare så var beteendet i fiskarna i det 
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ozonerade avloppet påverkat, då de verkade mer stressade av att placeras 
ensamma i ett nytt akvarium i slutet av försöket. Dessa resultat kan peka på att 
ozoneringen kan förändra den kemiska sammansättningen i avloppsvattnet, och 
därigenom påverka fiskar på nya sätt. 
Ozonets nedbrytning av läkemedel är sällan fullständig, och det har visat sig 
att ozonering kan bilda restprodukter. Hur giftiga (toxiska) dessa ämnen är finns 
det dock relativt lite kunskap kring. Därför studerades de tre vanliga 
läkemedlena diklofenak, karbamazepin och oxazepam och hur ozonering av dem 
påverkade deras toxicitet i sebrafisk-embryon. Det visade sig att diklofenak och 
karbamazepin kunde tas bort från vattnet med över 90%, medan oxazepam var 
svårare att bryta ned (ungefär 20%). Ozoneringen av diklofenak tog även 
effektivt bort dess giftiga effekter på embryona. Däremot orsakade ozonering att 
de skadliga effekterna av karbamazepin och oxazepam ökade, vilket var 
överraskande och lite oroande. Karbamazepinets restprodukter har tidigare 
identifierats, och med hjälp av denna information kunde vi isolera och testa fyra 
olika restprodukter av karbamazepin. Detta möjliggjorde en till studie på 
sebrafiskembryon där vi för första gången kunde bevisa att två ämnen, BQM och 
BQD, stod för de ökade skadliga effekterna efter ozonering av karbamazepin.  
Att ozonering av läkemedel bildar toxiska restprodukter är problematiskt. Vi 
bör undvika att skapa mer skada än nytta när vi förbättrar reningen av 
avloppsvatten. Lyckligtvis verkar det som att restprodukter kan brytas ned med 
hjälp av mikroorganismer i filter som avloppsvattnet passerar efter ozoneringen. 
Även olika tillägg i ozoneringen, som till exempel katalysatorer, kan förhindra 
uppkomsten av restprodukter. Problemet med läkemedelsrester i miljön kommer 
dock förmodligen behöva flera olika typer av lösningar. Exempelvis att utveckla 
nya mediciner som lättare bryts ned till icke toxiska restprodukter, och 
uppsamling av urin i toaletter som kan renas separat. Forskningen som syftar till 
en renare vattenmiljö, fri från läkemedelsrester, går framåt. 
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A B S T R A C T
Pharmaceutical residues and other micro-contaminants may enter aquatic environments through eﬄuent from
sewage treatment plants (STPs) and could cause adverse eﬀects in wild ﬁsh. One strategy to alleviate this si-
tuation is to improve wastewater treatment by ozonation. To test the eﬀectiveness of full-scale wastewater
eﬄuent ozonation at a Swedish municipal STP, the added removal eﬃciency was measured for 105 pharma-
ceuticals. In addition, gene expression, reproductive and behavioral endpoints were analyzed in zebraﬁsh (Danio
rerio) exposed on-site over 21 days to ozonated or non-ozonated eﬄuents as well as to tap water. Ozone treat-
ment (7 g O3/m3) removed pharmaceuticals by an average eﬃciency of 77% in addition to the conventional
treatment, leaving 11 screened pharmaceuticals above detection limits. Diﬀerences in biological responses of the
exposure treatments were recorded in gene expression, reproduction and behavior. Hepatic vitellogenin gene
expression was higher in male zebraﬁsh exposed to the ozonated eﬄuent compared to the non-ozonated eﬄuent
and tap water treatments. The reproductive success was higher in ﬁsh exposed to ozonated eﬄuent compared to
non-ozonated eﬄuent and to tap water. The behavioral measurements showed that ﬁsh exposed to the ozonated
STP eﬄuent were less active in swimming the ﬁrst minute after placed in a novel vessel. Ozonation is a capable
method for removing pharmaceuticals in eﬄuents. However, its implementation should be thoroughly evaluated
for any potential biological impact. Future research is needed for uncovering the factors which produced the in
vivo responses in ﬁsh.
1. Introduction
Pharmaceutical residues in domestic and industrial wastewaters
pollute the aquatic environment worldwide (aus der Beek et al., 2016;
Fent et al., 2006; Hughes et al., 2013). Conventional sewage treatment
plants (STPs) are not designed to eﬃciently remove pharmaceuticals
(Verlicchi et al., 2012). Some pharmaceuticals, such as oxazepam,
bioaccumulate in several trophic levels of aquatic food webs (Lagesson
et al., 2016). This suggest that pharmaceutical contamination of aquatic
ecosystems could aﬀect biodiversity and potentially also ecosystem
functioning of recipients (Jonsson et al., 2015). In line with this, several
studies have shown that environmentally relevant pharmaceutical
concentrations can aﬀect ecologically important traits in ﬁsh. For ex-
ample, ﬁsh exposed to synthetic progestins at low ng L−1 concentra-
tions may downright fail to reproduce (Zeilinger et al., 2009).
Estrogens, natural and synthetic, induce female speciﬁc hormone ex-
pression (vitellogenin, VTG) in males and produce intersex individuals
with diminished reproductive function at levels found downstream
from some sewage treatment plants (Kidd et al., 2007; Örn et al., 2016).
The ubiquitous non-steroid anti-inﬂammatory drug diclofenac cause
kidney damage in ﬁsh exposed at near environmentally relevant con-
centrations (Näslund et al., 2017). Psychoactive pharmaceuticals are
also present in water bodies inﬂuenced by STP eﬄuents (Grabicova
et al., 2017). Lab and ﬁeld studies have shown that oxzepam, an an-
xiolytic benzodiazepine, impacts ﬁsh behavior and could in turn aﬀect
whole populations (Brodin et al., 2013; Klaminder et al., 2016).
Ozonation is emerging as a potential method to improve wastewater
treatment (Eggen et al., 2014). Ozone and ozone-generated OH radicals
react readily with molecules of electron rich moieties, and have the
capacity to decrease concentrations of pharmaceuticals and other
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micro-contaminants, often with high eﬃcacy (Lee and von Gunten,
2016). Diclofenac and ethinylestradiol, for example, have been shown
to be eﬃciently removed (∼99%) by ozone (Hollender et al., 2009;
Snyder et al., 2006; Sun et al., 2017; Ternes et al., 2003). It is however
important to highlight that ozonation of the parent compound does not
necessarily cause total mineralization of the compound. Partially oxi-
dized ozonation by-products may have deleterious eﬀects on aquatic
biota such as ﬁsh (Prasse et al., 2015). Bromate and N-Ni-
trosodimethylamine (NDMA) are known ozonation by-products of
toxicological concern (Zimmermann et al., 2011). Estrogenic chemicals
are also partially degraded and generates ozonation by-products which
could induce potentially adverse eﬀects (Pereira et al., 2011).
Since the nature of STP eﬄuents and ozonation strategies ﬂuctuates
strongly depending on season, abiotic conditions, time and location, it
is imperative to gather as much knowledge of these diﬀerent settings as
possible. Previous studies have reported various outcomes from ozo-
nated STP eﬄuent exposure on ﬁsh. Examples from studies on rainbow
trout larvae has suggested that ozone may increase (Stalter et al., 2010)
or decrease (Margot et al., 2013) STP eﬄuent toxicity. Samuelsson et al.
(2011) showed consistent changes in the blood plasma composition of
ﬁsh exposed to sewage eﬄuents treated with a high (15 g O3/m3) but
not a low (5 g O3/m3) concentration of ozone. To what extent it re-
presented an adverse eﬀect is not known. While the capability of ozone
to remove pharmaceuticals and other micro-contaminants from ef-
ﬂuents is promising, the biological eﬀect outcome is of great im-
portance to study in order to safeguard the quality of the aquatic en-
vironment. The present study investigated in vivo responses in zebraﬁsh
(Danio rerio) exposed on site at a lab located in Knivsta STP, Sweden,
equipped with a parallel full scale ozonation stage. Chemical analysis
was performed in order to assess the eﬃciency of ozone to reduce
pharmaceutical concentrations in the conventionally treated STP ef-
ﬂuent. The major aim of the work was to detect endocrine, reproductive
and behavioral eﬀects in ﬁsh and its progeny exposed to the conven-
tional STP eﬄuent. Furthermore, we sought to elucidate if any such
eﬀects were either abated or ampliﬁed by eﬄuent ozonation.
2. Materials and methods
2.1. Knivsta STP
Knivsta STP is located 50 km north of Stockholm, Sweden. The
wastewater is collected in a combined sewer system. Knivsta STP has a
design capacity of 13 000 population equivalents (PE) (calculation base
70 g BOD7 per PE and day) and in 2015 the plant treated municipal and
to a smaller extent industrial wastewater from 12 000 PE in the Knivsta
municipality. The treatment at Knivsta STP includes ﬁve major steps:
pretreatment, primary sedimentation including chemical precipitation,
biological treatment, secondary sedimentation and post-chemical pre-
cipitation. The pretreatment lines consist of screens with 3mm bar
distance followed by aerated grit chambers where ferric chloride so-
lution is added for chemical precipitation of phosphor. Following pre-
treatment, primary sedimentation basins remove primary and chemical
sludge. In the ﬁrst of the two biological treatment steps, organic sub-
stances are degraded by the contact stabilization activated sludge
concept. The activated sludge is separated in secondary sedimentation
tanks. The wastewater is lifted to a second aerated biological treatment
containing carriers to facilitate nitriﬁcation. Finally, the wastewater is
distributed to ﬂocculators where ferric chloride solution is added for
removal of remaining phosphor. Subsequent sedimentation tanks re-
move the chemical ﬂocs. In 2015, mean hydraulic retention time for
wastewater in the treatment plant was 38 h, and the results for eﬄuent
standards were<3mg/L BOD7, 9mg/L total nitrogen, 0.11mg/L total
phosphor and 0.09mg/L ammonia nitrogen (Roslagsvatten, 2016).
2.2. Ozonation plant
A full-scale ozonation step was designed, partly constructed and
operated by the KTH Royal Institute of Technology to allow studies of
ozonation and its eﬀects on chemical and biological status of the ef-
ﬂuent from Knivsta STP. The ozonation step was divided into two
parallel lines which had a total maximum capacity of 560m3 eﬄuent
wastewater/h and included lifting pumps, production and injection of
ozone, static mixers, contact tanks with compartments and ﬁnal contact
ﬁlters. Each line contained two lifting centrifugal pumps (APEX ISF C,
Bristol, UK), one static mixer (NR Mixer, Statiﬂo International Ltd, UK),
one 50m3 stainless steel contact tank with 5m water depth and two
compartments, one ozone destructors for oﬀ-gas (Primozone, Sweden),
two contact ﬁlters with a total area of 2×12.7 m2 ﬁlled with 1m light
expanded clay aggregates (Leca, Saint-Gobain Linköping, Sweden) for
potential stripping or quenching of ozone residues. The ozone was
produced from evaporated liquid oxygen with>99.5% O2
(YaraPraxair, Sweden) by an ozone generator with a maximum pro-
duction capacity of 2.4 kgO3/h (GM48, Primozone, Sweden). The ad-
dition of ozone was ﬂow proportional up to 340m3/h at a dose of
7 gO3/m3, when the ﬁxed maximum amount of 2.4 kg ozone/h was
added giving a decreasing dose with further increasing ﬂow. The water
depth in the contact tanks was adjustable to 3, 4 or 5m. After the
ozonation step, the treated eﬄuent passed the existing polishing pond
before discharging into the receiving water, the small river Knivstaån.
2.3. Chemical analysis
A total 105 pharmaceuticals of various therapeutic classes were
searched for in the eﬄuent samples by online solid phase extraction and
liquid chromatography tandem mass spectrometry (see Supplementary
Material for full list). The method is described in detail in a previous
study (Lindberg et al., 2014). In short, online extraction of ﬁltered and
acidiﬁed eﬄuent samples was performed using an OASIS HLB
(20mm×2.1mm i.d., 15 μm particle size, Waters, Milford, Massa-
chusetts, USA); chromatography was made by the use of a Hypersil
GOLD aQ C18 (50mm×2.1mm i.d., 5 μm particle size, Thermo Fisher
Scientiﬁc, San Jose, CA, USA), or by a Varian Pursuit C18
(150mm×2.0mm i.d., 5 μm particle size, Agilent Technologies, USA);
pharmaceuticals were analyzed using a TSQ Quantum Ultra EMR triple
quadrupole mass spectrometer (Thermo Fisher Scientiﬁc, San Jose, CA,
USA) and quantiﬁed by means of internal standards.
2.4. Zebraﬁsh exposure system
The mobile laboratory (isolated 10 ft ISO-container) was positioned
adjacent to the conventional STP eﬄuent pipeline and post-ozonation
outgoing pipeline. Water from these two points were continuously
pumped into two separate 60 L polyethylene plastic barrels inside the
container. A third barrel was connected to the municipal drinking water
network ﬁltered by a carbon ﬁlter. An ozonated tap-water treatment
group was not included in this study due to space constraints and
technical limitations. Each barrel continuously supplied three aqua-
riums at a continuous ﬂow of 0.1 L/min. The experimental design thus
consisted of three treatment groups (STP eﬄuent, ozonated STP ef-
ﬂuent and tap water control) with three replicates each. Fluorescent
lights installed above the aquariums kept a 12:12 h light cycle. Each
aquarium was equipped with an immersion heater maintained a 25 °C
and the water was aerated by oxygen stones. The air temperature inside
the laboratory container was kept at approximately 20 °C. All water and
air temperatures were constantly monitored and logged using
LoggerSoft software and probes (WebIQ AB, Sweden). Water quality
parameters (pH, conductivity and ammonia) were regularly measured
in all replicate aquariums.
The 21 day exposure study at the ozone facility in Knivsta took place
between November 4th and November 25th 2015. Adult zebraﬁsh (one
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year old) were acclimatized and introduced into the 9 replicate aqua-
riums in groups of 10 individuals (total n= 90). Each replicate con-
sisted of 5 putative males and 5 putative females. The ﬁsh were fed once
daily with Sera Vipan® (Sera, Germany) and observed for signs of stress,
injury and/or mortality during the exposure period. The study was
conducted in accordance with the ethical permit DNR79-2014 issued by
the Animal Ethics Committee in Gothenburg, Sweden.
2.5. Fecundity and embryo toxicity tests
Fecundity measurements were performed during the last seven days
of the exposure, in accordance to previous studies measuring fecundity
in zebraﬁsh (e.g. Lister et al., 2009). Metal mesh cages (5 mm mesh
size) was placed in each aquarium to gather the ﬁsh and prevent them
from consuming any eggs. All spawned eggs were siphoned from the
bottom of the aquarium 30min after the light was turned on (9.30 am).
The number of fertilized, non-fertilized and damaged (inﬂated or lost
chorion) eggs were counted in Petri dishes. Fertilized eggs (n= 24)
from the ﬁrst successful spawning event of each replicate (n=3 per
treatment) were transferred individually with 1mL of water from its
corresponding aquarium into 48 well plates. The plates were moved to
our laboratory facilities (12:12 h light cycle, 26 °C air temperature).
Mortality and malformations among the collected embryos were as-
sessed at one, two and six days post fertilization (dpf).
2.6. Larvae locomotion test
The larvae locomotion (movement) response to alternating dark and
light periods was tracked and recorded using the ZebraBox (ViewPoint,
France) tracking system and ZebraLab software. The same 48 well
plates containing six dpf larvae collected from the ﬁrst successful
spawning event (see Section 2.5) were used for the larvae locomotion
test. Each plate was inserted into the ZebraBox chamber at between 12
pm and 6 pm. Each plate was acclimatized in the chamber for 10min
prior to recording to decrease handling-induced stress in the larvae. The
lighting protocol involved four alternating 0% light intensity (hence-
forth denoted D1 and D2) and 100% light intensity (henceforth denoted
L1 and L2) 10min periods (D1→ L1→D2→ L2). Tracking data con-
sisted of individual total locomotor activity aggregated each minute for
40min. Dead and/or malformed larvae were omitted from the tracking
data analysis.
2.7. Adult behavioral test
At the termination of the 21 day exposure period all adult ﬁsh were
individually transferred to non-transparent glass beakers (∅ 120mm)
along with 0.5 L of water from its corresponding aquarium. Four bea-
kers placed on an IR light table were recorded simultaneously by an
overhead mounted IR camera. Fish were distributed randomly from the
treatment groups into the beakers. Total locomotor activity tracking
data was acquired each minute by the ZebraLab software during a
10min period after placement in the beakers.
2.8. Liver tissue sampling and gonad histology
After behavioral recording the ﬁsh were euthanized by a blow to the
head and decapitated. The livers were dissected and snap-frozen in li-
quid nitrogen and kept at−70 °C for subsequent mRNA extraction. The
trunk part of each individual ﬁsh were placed in separate plastic his-
tology cassettes and ﬁxed in phosphate-buﬀered formaldehyde. The
samples were embedded in paraﬃn blocks after ﬁxation and dehydra-
tion. Sections were cut and stained by haematoxylin–eosin and then
evaluated under light microscopy. Males were classiﬁed as sexually
mature if the testis contained mature spermatozoa. Females were
classiﬁed as sexually mature if the ovary contained oocytes with vi-
tellogenic yolk granules. Oocyte maturation ovary was further
evaluated histologically by counting: 1) primary oocytes, 2) cortical
alveolar oocytes and 3) vitellogenic oocytes (Selman et al., 1993). The
proportions of these three stages of oocytes were determined in one
representative longitudinal section from each female. The histological
evaluations of gonads were done blindly without knowledge of treat-
ments.
2.9. mRNA extraction and qRT-PCR
Liver tissues were homogenized by Precellys Evolution (Bertin in-
struments, France) system equipped with liquid nitrogen cooling. Each
sample was placed in a 2mL Precellys homogenizing tube with 500 μL
RLT Plus buﬀer from the QiaSymphony RNA kit (Qiagen, Germany).
After completion of the protocol (2× 30 s at 6000 rpm, 30 s pause)
400 μL supernatant was transferred to new 2mL Eppendorf tubes and
inserted into the QiaSymphony SP instrument (Qiagen, Germany) for
RNA extraction. The RNA integrity number (RIN) and RNA concentra-
tion of the samples were measured in a 2100 Bioanalyzer system
(Agilent Technologies, USA). All samples had a RIN of between 7.4 and
9.5 (mean ± sd: 8.5 ± 0.4) and were included in the downstream
qRT-PCR reactions.
Primers for the transcripts ACTB (Beta actin), CYP1A1, ERα, VTG-2
(see Supplementary Material for information of oligonucleotide se-
quences, accession numbers and references) were ordered from and
synthesized by Euroﬁns Genomics. Forward and reverse primers were
added to each reaction respectively (200 nM each). Primer eﬃciency
was conﬁrmed before qRT-PCR of experimental samples began.
Samples (100 ng template RNA per reaction) were run in duplicates in
single reaction tubes with a total reaction volume of 20 μL (KAPA
SYBR® FAST one-step qPCR kit) in a Rotor-Gene 3000 instrument
(Corbett Research, Australia). A non-template control (NTC) was in-
cluded in each batch. The qPCR protocol consisted of holding 42 °C for
5min (reverse transcription), 95 °C for 3min (enzyme activation) and
40 cycles of alternating 95 °C (3 s), 60 °C (20 s) and 72 °C (20 s). A melt
curve analysis was performed following each reaction to ensure speciﬁc
product ampliﬁcation and check for primer dimer formation. Reaction
products of the genes of interest were sent to Macrogen for sequencing.
The resulting sequencing data was run on the NCBI Basic Local
Alignment Search Tool (BLAST) to ensure product speciﬁcity. Relative
mRNA expression was calculated by the E-ΔΔct method as described by
(Livak and Schmittgen, 2001). Beta-actin (ACTB) was selected as a re-
ference gene for normalization. Hepatic gene expression data from each
male was used to calculate treatment means based on the three aqua-
rium replicates.
2.10. Statistics
Data management, statistical modelling and ﬁgures was done using
R software version 3.3.2 with the RStudio version 1.0.153 interface (R
Core team, 2016; RStudio Team, 2016). Data were analyzed by one-way
ANOVA and Tukey honest signiﬁcance (HSD) test post-hoc test. Each
aquarium (n= 3 per treatment) was considered an experimental unit.
ANOVA and post hoc tests were considered signiﬁcant if p < .05.
Proportional data (e.g. oocyte stages distributions and larvae mortality)
were arcsine-transformed prior to statistical modelling. Outliers were
excluded from the mRNA expression data based on Grubbs’ test
(Grubbs, 1969; Komsta, 2011). Non-normal data were log-transformed
in order to meet normality assumptions. Behavioral and cumulative egg
production data were ﬁtted as hierarchal mixed linear models using the
nlme R package (Pinhiero et al., 2017). Group diﬀerences were assessed
by least-square means comparison with Tukey’s HSD p-value adjust-
ment using the lsmeans R package (Lenth, 2016). To account for re-
peated measurements from the same subject an autoregressive corre-
lation structure of lag 1 on the error term was set. All ﬁgures were made
using the ggplot2 R package (Wickham, 2009).
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3. Results and discussion
3.1. Ozone removal eﬃciency
Results from the chemical analysis of pharmaceuticals for the ef-
ﬂuent and the ozonated eﬄuent from Knivsta STP are summarized in
Table 1. Of the 105 screened pharmaceuticals (complete list available
as Supplementary Material), 24 were detected in the eﬄuent samples
from Knivsta STP during the exposure weeks. The ozone removal eﬃ-
ciency was on average 77% at an ozone dose of 7 g O3/m3. Of the 24
detected pharmaceuticals, 13 were removed to concentrations below
the limit of quantiﬁcation (LOQ). Total organic carbon (TOC) was on
average 13.2 mg C/L in the eﬄuent and 12.0 mg C/L in the ozonated
corresponding to 8.6% removal of TOC. The presence and identities of
ozonation by-products were not analyzed.
The average ozone removal eﬃciency of pharmaceuticals (77%)
was slightly lower than the target value of 80%, probably caused by an
insuﬃcient ozone dose in relation to the concentration of organic
substances in the eﬄuent. The ozone dose was set to 7 g O3/m3 during
the start-up of the ozonation plant which the corresponded to a speciﬁc
ozone dose of 0.65 g O3/g TOC in the feed to the ozonation plant re-
sulting in higher than 80% pharmaceutical removal. During the ex-
posure weeks in November the average TOC concentration in the ef-
ﬂuent had increased from 11 to 13.2 mg C/L corresponding to 0.53 g
O3/g TOC in the feed to the ozonation plant but unfortunately the TOC
was not analyzed at the time of the exposure, so the ozone dose was not
adjusted.
3.2. Eﬀects on male zebraﬁsh hepatic gene expression
The male hepatic gene expression of the three genes ERα, CYP1A1
and VTG-2 is displayed in Fig. 1. VTG-2 was induced 17-fold
(p= .0196) in the ozonated STP eﬄuent treatment group compared to
the tap water control group. CYP1A1 was induced two-fold compared to
the tap water controls, but the diﬀerence was not statistically sig-
niﬁcant (p= .0825). Gene expression of ERα also showed a non-sig-
niﬁcant (p= .1077) tendency of induction in both the conventional and
ozonated STP eﬄuent.
The main driver of ﬁsh oocyte growth and maturation is the hy-
pothalamic-pituitary-gonadal (HPG) axis. The gonadotropins, follicle
stimulating hormone (FSH) and lutenizing hormone (LH) are key hor-
mones in the HPG axis, present in plasma prior to and during spawning
(Nagahama, 2002). The gonadotropins stimulate the ovary which in-
itiates 17β-estradiol production and in turn signals the liver to produce
vitellogenin (Clelland and Peng, 2009). Vitellogenin, or egg yolk pre-
cursor protein, is highly conserved in oviparous vertebrates and is
produced in the female (Byrne et al., 1989). The serum estrogen con-
centration correlates with vitellogenin mRNA levels in ﬁsh hepatocytes
Table 1
Concentrations of quantiﬁed pharmaceuticals in conventional STP eﬄuent and
after additional treatment by ozonation in Knivsta STP. The removal eﬃciency
(%) was calculated based on the sum of API concentrations in each sample
(n=3). If the concentration of a pharmaceutical was below its limit of quan-
tiﬁcation (LOQ), it was given the value LOQ/2.
API STP
eﬄuent
(ng L−1)
Ozonation
eﬄuent
(ng L−1)
Ozonation
Removal
eﬃciency (%)
LOQ
(ng L−1)
Atenolol 633 209 56 15
Bisoprolol 126 48 49 4
Carbamazepine 207 <LOQ 97 7.5
Citalopram 351 <25 90 20
Clindamycine 74 <LOQ 98 3
Codeine 219 <LOQ 94 20
Diclofenac 620 <LOQ 99 15
Eprosartan 214 <LOQ 96 15
Erythromycine 153 <LOQ 67 100
Fexofenadine 148 <LOQ 97 10
Flecanide 137 55 76 2
Fluconazole 200 147 24 7.5
Irbesartan 162 84 44 3
Memantine 12 4.8 52 4
Metoprolol 1244 406 63 15
Mirtazapine 68 <LOQ 84 20
Oxazepam 243 117 42 10
Ranitidine 125 <19 84 20
Rosuvastatin 121 <LOQ 90 20
Sotalol 323 <LOQ 94 20
Sulfamethoxazol 258 <LOQ 97 15
Tramadol 298 60 87 20
Trimethoprim 173 <LOQ 99 4
Venlafaxine 178 <LOQ 67 20
Sum conc (ng L−1) 6392 1421 – –
Average removal
eﬃciency (%)
– – 77 –
Number of APIs 24 11 – –
Fig. 1. Gene expression (fold change – tap water control) of ERα, CYP1A1 and VTG-2 in male zebraﬁsh liver tissue (n= 3, mean+ sd). Diﬀerent letters indicate
signiﬁcant diﬀerences (Tukey’s HSD p < 0.05) in the expression of VTG-2 (ANOVA p= .0196). The gene expression data was normalized against the household gene
ACBT (the expression of which was not altered by any treatment).
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(Okumura et al., 2002). Estrogens bind to the estrogen receptors in
hepatocytes and initiates vitellogenin gene expression (Hara et al.,
2016). Induction of vitellogenin in male ﬁsh has been attributed to
exposure of estrogenic xenobiotics, making it a sensitive biomarker for
estrogenic exposure (Arukwe and Goksøyr, 2003). STP eﬄuents typi-
cally contain a multitude of diﬀerent xenobiotics with varying estro-
genic potency. Such mixtures may have an additive eﬀect on vitello-
genin induction (Sumpter and Jobling, 1995). In the present study we
did not detect the estrogenic parent compounds estradiol, estriol, es-
trone or ethinylestradiol at levels above LOQ (30–40 ng L−1) in either
ozonated or non-ozonated eﬄuent.
Ozone treatment has been reported to decrease the vitellogenin
gene expression levels in male ﬁsh induced by conventional STP ef-
ﬂuents (Cuklev et al., 2012; Gunnarsson et al., 2009). In the current
study however, exposure to the ozone treated STP eﬄuent un-
expectedly resulted in higher vitellogenin gene expression levels com-
pared with the other treatments. This might indicate that the chemical
composition of the eﬄuent has become more estrogenic due to ozo-
nation by-products, an outcome which has been illustrated in earlier
studies. Ozonation of a hospital wastewater eﬄuent has been shown to
produce chemicals which stimulate endogenous production of estrogens
in ﬁsh (Maletz et al., 2013). Furthermore, ozonation of 17β-estradiol
might increase its in vitro estrogenic activity, as indicated in laboratory
studies (Bila et al., 2007). The results we present in this study may thus
be associated with ozone-mediated estrogenicity speciﬁc to the pre-
sently studied STP eﬄuent and the applied ozonation procedure.
3.3. Eﬀects on zebraﬁsh reproduction
The fecundity diﬀered signiﬁcantly between the treatments; ﬁsh in
the ozonated STP eﬄuent group produced twice the amount of eggs
(p= .0021) as compared to both the tap water control and the con-
ventional STP eﬄuent (Table 2). The cumulative egg production per
female was conclusively greater in the ozonated STP eﬄuent group
(Fig. 2). The proportion of fertilized and damaged eggs did not diﬀer
signiﬁcantly between the treatments (Table 2).
The ﬁsh reproductive system is controlled by several hormonal and
paracrine pathways that may potentially become disrupted by xeno-
biotic chemicals. Prostaglandins are synthesized in the ovary and have
been implicated to induce egg production and spawning in female
zebraﬁsh (Lister and Van Der Kraak, 2008). Furthermore, pros-
taglandins may increase male spawning behaviors by acting as hor-
monal pheromones (Stacey et al., 2003). The nonsteroidal anti-in-
ﬂammatory drug ibuprofen is found in wastewater inﬂuenced aquatic
environment and has the capacity to impact the ﬁsh prostaglandin
synthesis (Han et al., 2010; Morthorst et al., 2013). The chemical
analysis in the present study did however not reveal any prostaglandin
interfering APIs.
One reason for increased fecundity in ﬁsh could be explained by low
concentrations of estrogenic xenobiotics, as shown in several lab stu-
dies. Exposure to ethinylestradiol in the 1 ng L−1 range induces egg-
laying in fathead minnow (Jobling et al., 2003). Increased egg pro-
duction has also been observed in gulf pipeﬁsh (Syngnathus scovelli)
exposed to low ethinylestradiol concentrations (2 ng L−1) (Rose et al.,
2013). Nonylphenol exposure may induce fecundity in Japanese me-
daka (Nimrod and Benson, 1998) and in fathead minnow (Giesy et al.,
2000). The increase in fecundity in the present study might partly be
caused by exposure to low concentrations of estrogenic compounds
present in the ozonated eﬄuent water. This could indicate that ozo-
nation, under the particular conditions of this study, created by-pro-
ducts more estrogenic than the parent compounds measured in the non-
ozonated STP eﬄuent.
While an increased production of eggs could potentially be a reac-
tion to an inhospitable environment, it could also be a response to an
ideal environment. Improved fecundity in ﬁsh exposed to ozonated
eﬄuents have been reported in previous literature. Egg production in
Japanese medaka (Oryzias latipes) exposed to ozonated STP eﬄuent in a
similar setup as the present study increased slightly, yet not signiﬁcant,
compared to control and conventional STP treatments (Altmann et al.,
2012). Increased egg production has been recorded in fathead minnow
(Pimephales promelas) exposed to ozonated STP eﬄuent (Ward and
DeGraeve, 1978). In these studies, as well as the present study, the
obtained overall quality of the ozonated eﬄuent treatment is possibly
the most optimal for the ﬁsh, thereby resulting in a normal reproductive
output. The tap water and non-ozonated STP eﬄuent may represent
sub-optimal conditions, thereby resulting in lower fecundity compared
with the ozonated STP eﬄuent. Thus, the reproductive outcome from
ﬁsh exposed to ozonated eﬄuent might not display an increase in re-
productive success but rather a normal level of reproduction.
Histological assessment of the ovarian sections (Fig. 3) revealed that
the ozonated STP eﬄuent treatment group contained a larger propor-
tion of vitellogenic stage oocytes than the tap water control (Fig. 4).
The proportion was also slightly larger in the conventional STP eﬄuent
treatment group compared to the tap water control group, albeit not
signiﬁcant (Fig. 4). The hormonal basis of oocyte maturation in female
ﬁsh is related to LH, which stimulates maturation inducing hormone in
the ovary (Nagahama and Yamashita, 2008). The results of the present
study shows that egg maturation was ampliﬁed in the ozonated STP,
perhaps due to endocrine active ozonation by-products or just optimal
water conditions. There were no signs of intersex in male ﬁsh (data not
Table 2
Summary of egg production data assembled during the last 7 days of the 21 day zebraﬁsh exposure. A spawning was considered successful if eggs were present after
the 30min spawning period after lights on (9.00 am–9.30 am). The numbers of fertilized and damaged eggs is presented as treatment replicate means ± standard
deviation (n=3) of quantity (n) and proportion (%) of the eggs collected.
Treatment Tank replicate Successful spawnings (out of 7) Fertilized eggs produced (per female, mean ± sd) Damaged eggs (per female, mean ± sd)
(n) (%) (n) (%)
Tap water control 1 5 34.4 ± 13.8 89.8 ± 5.0 5.3 ± 5.4 8.6 ± 4.3
2 5
3 6
STP eﬄuent 1 5 38.5 ± 1.9 94.2 ± 6.9 1.2 ± 0.8 4.9 ± 5.3
2 3
3 5
Ozonated STP eﬄuent 1 5 77.5 ± 7.5 * 83.2 ± 14.3 8.9 ± 2.3 15.3 ± 14.5
2 4
3 5
* Treatment diﬀerence (ANOVA p= .0021, Tukey's HSD p < .05).
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shown). All the males had comparable amounts of spermatozoa in their
seminiferous tubules.
3.4. Larvae locomotor activity, mortality and malformations
Embryos collected from the fecundity assessment stage were al-
lowed to develop for 6 dpf in its corresponding aquarium water before
locomotion testing. There were no statistically signiﬁcant diﬀerences in
mortalities or malformations between the treatment groups (Table 3).
The larvae locomotion test did not reveal any diﬀerences in activity
between the treatment groups (Fig. 5). Larvae locomotor activity has
been used as a sublethal endpoint for assessing developmental tox-
icology in exposed ﬁsh progeny (MacPhail et al., 2009). Several dif-
ferent classes of suspected neurotoxic chemicals has been screened for
neurobehavioral eﬀects using this approach (Ellis et al., 2012; Ulhaq
et al., 2013). In the present study, such eﬀects were not detected.
3.5. Swimming activity in adult zebraﬁsh
Fish exposed to the ozonated STP eﬄuent were signiﬁcantly less
active (p < .0001) during the ﬁrst minute of the trial (Fig. 6). Over
time the activity of ﬁsh in the ozonated treatment increased to that of
the other treatment groups. There were no evident diﬀerence in activity
between the sexes (p= .0656) and therefore the statistical model was
run including both males and females.
A reduced swimming activity in zebraﬁsh is generally associated
with an increased stress phenotype (Kalueﬀ et al., 2013). The stress
response is important for coping and adapting to the environment but
may lead to a pathological outcome in the long run (Bonga, 1997). The
serotonergic system is associated with stress in ﬁsh where stressed in-
dividuals have increased levels of serotonin in the brain (Winberg et al.,
1992). Serotonin modulates the hypothalamus-pituitary-interrenal axis,
or the ‘stress-axis’, in ﬁsh. Serotonin also stimulates the reproductive
neuroendocrine axis in ﬁsh by increasing the release of gonadotropins
from the pituitary gland, which controls gonad maturation and egg
release (Somoza et al., 1988). Whether endocrine disruption of the
serotonergic system is inﬂuencing the observed fecundity and stress
eﬀects in the current study remains speculative at this point. However,
recent experimental evidence supports the notion that STP eﬄuent
ozonation modulates serotonergic responses in ﬁsh. Rainbow trout in-
jected intraperitoneally with ozonated wastewater extract has been
shown to induce brain serotonin levels (Maya et al., 2017). It is diﬃcult
to extrapolate whether these eﬀects, reported both in previous litera-
ture and in the present study, would have an adverse impact on wild
ﬁsh populations.
Fig. 2. Total cumulative number of fertilized eggs produced per female and day during the last 7 days of the 21 day exposure (n=3, mean ± sd). Diﬀerent letters
indicate signiﬁcant diﬀerences between the treatments (pair-wise Tukey’s HSD p < 0.05) at day ﬁve, six and seven (ANOVA p= .0087).
Fig. 3. Microphotograph of a zebraﬁsh ovarian section exemplifying a vitello-
genic (A), cortical alveolar (B) and primary oocyte (C).
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4. Conclusions
We have reported that 24 of the 105 screened pharmaceuticals were
present in the conventionally treated STP eﬄuent at concentrations
above LOQ. Ozonation removed on average 77% of the concentrations
of these 24 pharmaceuticals. The male hepatic gene expression of VTG-
2 was induced in ﬁsh exposed to ozonated STP eﬄuent indicating an
estrogenic eﬀect. The estrogenicity was not of such magnitude that it
negatively aﬀected fecundity. On the contrary, zebraﬁsh exposed to
ozonated eﬄuent exhibited a two-fold increased fecundity compared to
both the tap water control and conventional STP eﬄuent treatment
groups. This ambiguity could partly be explained by either the ozonated
STP eﬄuent being the best spawning environment for the ﬁsh, or be the
result of estrogenic ozonated by-products stimulating reproduction. The
occurrence of ozonation by-products were however not analyzed in the
ozonated STP eﬄuent.
Fig. 4. Proportion of primary oocytes, cortical alveolar oocytes and vitellogenic oocytes within the ovary (n= 3, mean+ sd). Diﬀerent letters indicate signiﬁcant
diﬀerences (Tukey’s HSD p < 0.05). Ovaries in ﬁsh exposed to the ozonated STP eﬄuent treatment group contained more vitellogenic oocytes (C) compared to the
tap water control (ANOVA p= .0424).
Table 3
Mortality at 24, 48 and 144 hpf and malformations at 144 hpf in zebraﬁsh larvae progeny from the ﬁrst successful spawning in the corresponding replicate tank
(n=3, mean ± sd).
Mortality at 24 hpf (%) Mortality at 48 hpf (%) Mortality at 144 hpf (%) Malformations at 144 hpf (% of alive)
Tap water control 0 ± 0 9.7 ± 9.6 13.9 ± 17.3 13.4 ± 16.1
STP eﬄuent 26.1 ± 45.2 36.5 ± 36.3 50 ± 45.1 5 ± 7.1
Ozonated STP eﬄuent 2.8 ± 4.8 5.6 ± 2.4 34.7 ± 18.8 7.9 ± 9.7
Fig. 5. Larvae locomotor activity during four alternating 10min dark (D1 and D2) and light (L1 and L2) periods. The left panel shows locomotor activity per minute
(n=3, mean), the right panel shows locomotor activity per period (n=3, mean+SD). The locomotor activity response to alternating light and dark periods was not
diﬀerent between the treatment groups.
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The results from the present study highlight the importance of
monitoring the implementation of full-scale STP eﬄuent ozonation by
both chemical and biological eﬀect screening. Future research is needed
for uncovering the potencies and identities of ozonated by-products that
cause in vivo responses in ﬁsh.
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Table 1. List of the 105 analyzed APIs. 
Pharmaceutical substance name   
Alfuzosin Flecainide Sertraline 
Alprazolam Fluconazole Sulfamethoxazol 
Amiodarone Flunitrazepam Tamoxifen 
Amytriptyline Fluoxetine Telmisartan 
Atenolol Flupentixol Terbutaline 
Atorvastatin Fluphenazine Tetracycline 
Atracurium Flutamide Tramadol 
Azelastine Glibenclamide Trihexyphenidyl 
Biperiden Glimepiride Trimethoprim 
Bisoprolol Haloperidol Venlafaxine 
Bromocriptine Hydroxyzine Verapamil 
Budesonide Ibuprofen Zolpidem 
Buprenorphine Irbesartan  
Bupropion Ketoconazole  
Carbamazepin Ketoprofen  
Chlorpromazine Levomepromazine  
Chlorprothixene Levonorgestrel  
Cilazapril Loperamide  
Ciprofloxacin Maprotiline  
Citalopram Meclozine  
Clarithromycine Medroxyprogesterone  
Clemastine Megestrol  
Clindamycin Memantine  
Clomipramine Metoprolol  
Clonazepam Mianserin  
Clotrimazol Miconazole  
Codeine Mirtazapine  
Cyproheptadine Naloxone  
Desloratidin Naproxen  
Diclofenac Nefazodone  
Dicycloverine Norfloxacin  
Dihydroergotamine Ofloxacin/levofloxacin  
Diltiazem Orphenadrine  
Diphenhydramine Oxazepam  
Donepezil Oxytetracycline  
Duloxetine Paracetamol  
Eprosartan Paroxetine  
Estradiol Perphenazine  
Estriol Pizotifen  
Estrone Progesterone  
Ethinyl estradiol Promethazine  
Etonogestrel Ranitadine  
Fenofibrate Repaglinide  
Fentanyl Risperidone  
Fexofenadine Rosuvastatin  
Finasteride Roxithromycine  
2 
 
Table 2. Oligonucleotide sequences (5’ to 3’) of the primers used in the present study.  
Transcript  Oligonucleotide sequence Accession number Reference 
ACBT Forward ACAGGGAAAAGATGACACAGATCA AF025305 Lister and Van Der Kraak, 2008 
 Reverse CAGCCTGGATGGCAACGTA   
CYP1A1 Forward CTGGACGAAAACTCCAACCTG NM_131879 Lister et al., 2009 
 Reverse GATAGTGTCGAAACCGGCTCC   
ERα Forward AAACACAGTCGGCCCTACAC AJ414566 Arukwe et al., 2008 
 Reverse GCCAAGAGCTCTCCAACAAC   
VTG-2 Forward GGTGACTGGAAGATCCAAG AY729645 Jin et al., 2008 
 Reverse TCATGCGGCATTGGCTGG   
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 First time evaluation of Danio rerio embryo toxicity of ozonated pharmaceuticals.
 Ozonation of carbamazepine increased the toxicity in all tested endpoints.
 Three analyzed carbamazepine ozonation by-products were formed.
 Diclofenac toxicity was completely eliminated by ozonation.
 Ozonated oxazepam exposure elicited swimming behavioral changes in 6 day old larvae.
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a b s t r a c t
Pharmaceutical residues are polluting the surface water environments worldwide. Sewage and waste-
water treatment, therefore, needs to be improved in order to remove pharmaceutical residues from the
efﬂuent. One such treatment improvement is efﬂuent ozonation. Even though ozonation has proven to
be very efﬁcient in reducing pharmaceutical parent compound concentrations in wastewater efﬂuents,
much remains unclear regarding potentially toxic ozonation by-product (OBP) formation. In this study,
we sought to elucidate the aquatic toxicity of ozonated pharmaceuticals in zebraﬁsh (Danio rerio) em-
bryos in a static 144 h post fertilization (hpf) ﬁsh embryotoxicity (ZFET) assay. Three pharmaceuticals
commonly detected in wastewater efﬂuents, i.e. carbamazepine, diclofenac, and oxazepam, were selected
for testing. Toxicity was assessed before and after 1min ozonation (0.053mg L1 peak O3 concentration)
and 10min ozonation (0.147mg L1 peak O3 concentration). Chemical analysis showed that carbamaz-
epine and diclofenac were largely removed by ozone (90± 11% and 97± 3.8%), whereas oxazepam was
removed to a lesser extent (19± 5.7%). The ZFET assay revealed diverging toxicities. Diclofenac embry-
otoxicity decreased with increasing ozonation. Oxazepam did not cause embryotoxicity in the ZFET assay
either pre- or post ozonation, but larvae swimming activity was affected at 144 hpf. Carbamazepine
embryotoxicity, on the other hand, increased with increasing ozonation. Chemical analysis showed the
formation of two OBPs (carbamazepine-10,11-epoxide and 10,11-dihydrocarbamazepine), possibly
explaining the increased embryotoxicity. The results of this study highlight the importance of new
chemical and toxicological knowledge regarding the formation of OBPs in post-ozonated efﬂuents.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Pharmaceutical residue pollution is a considerable challenge
regarding water quality and ecological status of the aquatic envi-
ronment (Fent et al., 2006). A major pollution pathway into the
aquatic environment is domestic efﬂuent from municipal sewage
treatment plants (STPs). STPs are often not capable to efﬁciently
remove organic micropollutants such as pharmaceutical residues
from the efﬂuent (Luo et al., 2014). Thus, STPs discharge* Corresponding author. Box 7028, 750 07, Uppsala, Sweden.
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Contents lists available at ScienceDirect
Chemosphere
journal homepage: www.elsevier .com/locate/chemosphere
https://doi.org/10.1016/j.chemosphere.2019.03.034
0045-6535/© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Chemosphere 225 (2019) 191e199
pharmaceutical contamination into the surface water environ-
ments, elevating the concerns of adverse effects in aquatic biota
(aus der Beek et al., 2016; Hughes et al., 2013; Loos et al., 2013).
Conventionally treated municipal STP efﬂuents often contain the
anti-inﬂammatory drug diclofenac, the anti-epileptic carbamaze-
pine and the anxiolytic drug oxazepam in the range of several
hundred ng L1 (e.g. Lindberg et al., 2014; Pohl et al., 2018). Some
pharmaceuticals are refractory in nature and may have bio-
accumulative properties in the aquatic environment (Grabicova
et al., 2017). Since STP efﬂuents release pharmaceutical residues
into the recipient continuously, the resulting pollution can be
considered to be pseudo-persistent. A recent study has shown that
carbamazepine has been detected in all parts of the Baltic Sea
(Bj€orlenius et al., 2018). Effects on wildlife due to pharmaceutical
residues in the aquatic environment are not yet well understood,
but pharmaceuticals made for human and veterinary usage can
potentially affect non-target organisms such as ﬁsh (Gunnarsson
et al., 2008). Laboratory studies have shown how carbamazepine
(10 mg L1) produces xeno-estrogenic effects in ﬁsh (Yan et al.,
2018). Oxazepam (200 mg L1) affects wild ﬁsh behaviors impli-
cating adverse effects on an ecological scale (Brodin et al., 2013;
Klaminder et al., 2016). Other examples include diclofenac
(4.6 mg L1) adversely affecting three-spined stickleback (Gaster-
osteus aculeatus) kidney function (N€aslund et al., 2017). As a
consequence, regulations are being put in place to reduce the load
of pharmaceutical contamination in the aquatic environment.
Diclofenac has, for example, been added to the 2013/39/EU direc-
tive watch list of priority substances (European Union, 2015).
STP efﬂuent ozonation is being implemented in Sweden in order
to alleviate pharmaceutical pollution (Baresel et al., 2016). Ozone
has the capacity to reduce the pharmaceutical load of STP efﬂuents
(Prasse et al., 2015). Previous ecotoxicological evaluations have
shown beneﬁcial effects of whole-efﬂuent ozonation (e.g. Beijer
et al., 2017; Cuklev et al., 2012; Lundstr€om et al., 2010). Some
studies, however, have suggested increased toxicity in ﬁsh
following efﬂuent ozonation (e.g. Costa et al., 2014; Giebner et al.,
2016). While ozonation has proven to be very efﬁcient in
reducing pharmaceutical parent compound concentrations in STP
efﬂuents, the formation of potentially toxic ozonation by-products
(OBPs) remains insufﬁciently studied. Thus, it is important to
explore if and how the ozonation treatment of STP efﬂuents mod-
ulates the biological effect in aquatic organisms exposed to the STP
efﬂuent due to suspected OBP toxicity.
The present study aimed to determine the toxicity of untreated
and ozonated carbamazepine, diclofenac, and oxazepam. These
three particular pharmaceuticals were selected since they are
commonly detected in sewage efﬂuents and aquatic environments
in the EU (Loos et al., 2013). The toxicological evaluation was per-
formed using the zebraﬁsh (Danio rerio) embryo toxicity assay
(ZFET), which represents a robust whole organism aquatic toxicity
test for detecting effects on lethal and sublethal endpoints (Hill
et al., 2005). Furthermore, it can be combined with a behavioral
(larvae swimming activity) assay in order to detect neurobehavioral
effects due to developmental chemical exposure (Selderslaghs
et al., 2013). In addition, the ozonated extracts were screened for
four putative transformation products of carbamazepine to explain
observed toxicity.
2. Materials & methods
2.1. Chemicals
Carbamazepine (CAS number 298-46-4, purity 98%), diclofe-
nac sodium salt (CAS number 15307-79-6, purity 98%) and
oxazepam (CAS number 604-75-1, purity 98%) acquired from
Sigma-Aldrich (Sweden) were used in the study. Carbamazepine
and diclofenac were directly diluted into carbon ﬁltered tap water
(control water) at maximum nominal concentrations and then
serially diluted 1:2 (100, 50, and 25mg L1 for carbamazepine and
15, 7.5, and 3.8mg L1 for diclofenac). Oxazepamwas ﬁrst diluted in
dimethyl sulfoxide (DMSO, purchased from Sigma-Aldrich (Swe-
den), CAS number 67-68-5, purity 99%) at 100mgmL1, serially
diluted in DMSO 1:10 and thenmixed in control water to reach ﬁnal
nominal test concentrations of 10, 1 and 0.1mg L1 (0.01% DMSO).
Metabolite standards of carbamazepine: carbamazepine-10,11-
epoxide (Cbz-Ep, CAS number 36507-30-9, purity 98%), 10,11-
dihydro-10-hydroxycarbamazepine (DiOH-Cbz, CAS Number
29331-92-8, purity 99%), 10,11-dihydrocarbamazepine (Di-Cbz,
CAS Number 3564-73-6, purity 99%), and oxcarbazepine (Ox-Cz,
CAS Number 28721-07-5, purity 97.5%) were purchased from
Sigma-Aldrich (Sweden). Isotope-labeled internal standards of
oxazepam (D5) was acquired from lipomed AG (Sweden) and
diclofenac (13C6) was purchased from Sigma-Aldrich (Sweden).
Ultrapure water was produced by a Milli-Q Advantage Ultrapure
Water puriﬁcation system and ﬁltered through a 0.22 mm Millipak
Express membrane and an LC-Pak® polishing unit (Merk Millipore,
Billercia, MA). Methanol, acetonitrile and ammonium acetate were
all of high-performance liquid chromatography (HPLC)-grade and
purchased from Sigma Aldrich (St. Luis, MO, USA).
2.2. Experimental ozonation set-up
Ozonation was performed using an ozone generator (AB Aqua
Medic GMBH, Bissendorf, Germany) with a maximum ozone gen-
eration capacity of 100mg O3 h1 set up within a fume-hood. The
ozone was administered to the test solutions (v¼ 0.25 L, 25 C) by
diffusion stone in Erlenmeyer ﬂasks. The set-up performance was
evaluated before pharmaceutical ozonation and zebraﬁsh embry-
otoxicity tests. The ozone concentration was measured by the
LCK310 Ozone cuvette test (0.05e2mg L1 measurement range) in
a DR 3900™ spectrophotometer (Hach, Loveland, Colorado, United
States). Ozone concentrations in control water were determined
over the course of 135min continuous ozonation (Supplementary
Data Fig. S1). Based on the set-up evaluation, two doses of ozona-
tion were selected for pharmaceutical ozone treatment; 1min
ozonation (peak ozone concentration of 0.053mg ozone L1), and
10min ozonation (peak ozone concentration of 0.147mg ozone
L1).
Each pharmaceutical test solution and control water was ozo-
nated either 0, 1 or 10min directly prior to the ZFET assays (see
section 2.4). The pharmaceutical concentrations were determined
prior to ozonation by concentration-response range screening us-
ing the same ZFET methodology. Dissolved oxygen, conductivity
and pH were measured in all solutions directly post ozonation.
These water parameters did not differ between untreated nor
ozonated control water or pharmaceutical solutions (pH
8.20± 0.065, conductivity 440± 9.3 mS cm1, dissolved oxygen
94± 0.83%, Supplementary Data Table S1). Samples (2mL, one
sample per test solution) were collected and stored in glass vials
at 18 C for chemical analysis.
2.3. Chemical analysis
The chemical analysis method was based on a previously pub-
lished study (Koba et al., 2018). The samples were ﬁltered using a
regenerated cellulose syringe ﬁlter (0.22 mmpores). Onemilliliter of
the ﬁltered extract was placed in an autosampler vial with 10 ng of
the isotope-labeled internal standards of oxazepam 80 (D5) and
diclofenac (13C6) per aliquot of sample. The samples were analyzed
using liquid chromatography tandem-mass spectrometry (LC-MS/
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MS) with an LC system from Thermo Fisher Scientiﬁc, San Jose, CA,
USA and a triple-stage quadrupole MS/MS TSQ Quantiva (Thermo
Fisher Scientiﬁc). An Acquity UPLC BEH-C18 column (Waters,
100mm 2.1 i.d., 1.7 mm particle size from Waters Corporation,
Manchester, UK) was used as an analytical column. Injection vol-
ume was 10 mL for all samples. A heated electrospray ionization (H-
ESI) was used to ionize the target compounds. The spray voltage
was set to static: positive ion (V) 3500.00. Nitrogen (purity
>99.999%) was used as a sheath gas (50 arbitrary units), auxiliary
gas (15 arbitrary units) and sweep gas (2 arbitrary units). The
vaporizer was heated to 400 C and the capillary to 325 C. Two
selected reaction monitoring (SRM) transitions were monitored for
all analytes. Data were evaluated using TraceFinder™ 3.3 software
(Thermo Fisher).
2.4. Zebraﬁsh embryotoxicity tests
Groups of adult zebraﬁsh kept at 12/12 h light/dark conditions
were placed in stainless steel mesh spawning cages in the morning
at lights on (9:00e9:30 a.m.). Eggs were collected and assessed for
fertilization success where the spawning group with the highest
amount of fertilized eggs (>90%) was selected for testing. Each
treatment (control, low, medium and high pharmaceutical con-
centration with either 0, 1 or 10min ozonation, see Table 1) con-
sisted of 16 embryo replicates distributed in two 96-well plates. The
embryos were placed in individual wells including 250 mL treat-
ment water. The well plates were sealed with Paraﬁlm M (Bemis
NA, United States) for the duration of the exposure. The eggs were
exposed statically (i.e. test solutions were not renewed over time)
from fertilization until 144 h post fertilization (hpf).
Lethal (e.g. coagulation) and sublethal (e.g. incidence of yolk sac
and/or pericardial edemas etc.) endpoints were recorded at 24, 48
and 144 hpf. Representative malformation types are displayed in
Supplementary Data Fig. S5. At 48 hpf the heart rate was assessed in
the embryos by stereo microscopy. Time-lap photographing was
performed between ~50 and 144 hpf taking one picture per hour of
thewhole plates (Canon EOS 500D). Hatching timewas determined
for each embryo as the time for the photograph where the embryo
ﬁrst was observed as hatched. At 144 hpf, larvae locomotion
(movement) in response to alternating dark and light periods was
tracked using the ZebraBox tracking system and ZebraLab software
(ViewPoint, France). Each 96-well plate was placed in the Zebrabox
recording chamber between 1:00 and 3:00 p.m. After a preliminary
15min acclimatization in darkness, three interchanging light and
dark periods (10min each) were executed. The distance moved by
each larva (exceeding 3mm s1) was thus simultaneously recorded
and aggregated in 10 s intervals over the course of 45min. The
individual larvae total locomotionwas summed into three response
variables; swimming distance/min, total swimming distance
during darkness, and total swimming distance during light. Data
from affected embryos (malformed/dead) were excluded from the
locomotion test in order not to confound the analysis.
2.5. Statistics
The RStudio version 1.0.153 interface running R software version
3.3.2 was used for data analysis and visualization (R Core team,
2016; RStudio Team, 2016). Continuous parameters (e.g. heart
rate) were analyzed by one-way ANOVA followed by Dunnett's post
hoc test. The incidence of mortality and malformations were
combined into one binary response (affected/not affected) and
analyzed by Bonferroni adjusted Fisher's exact test. The level of
signiﬁcance (alpha) was set at 0.05. Figures were made using the
ggplot2 R package (Wickham, 2009).
3. Results & discussion
3.1. Ozone removal efﬁciency of carbamazepine, diclofenac, and
oxazepam
The nominal concentrations for carbamazepine and oxazepam
corresponded with themeasured concentrations on average by 59%
and 81% respectively (Table 1). These deviations were probably due
to issues of solubility and precipitation in water (for carbamaze-
pine) and DMSO (for oxazepam). The measured concentrations of
diclofenac were in good agreement with nominal concentrations
(Table 1). Ozonation for 1min removed 20 ± 3.4% carbamazepine,
25± 16% diclofenac, and 2.0± 4.4% oxazepam (Fig. 1). Increasing
ozone dosage time improved removal of the parent compound in
all three tested pharmaceuticals. Ozonation for 10min removed
90± 11% carbamazepine, 97± 3.8% diclofenac, and 19± 5.7% oxaz-
epam. As a comparison, ozonation at an STP equipped with a full-
scale ozonation plant removed 97% carbamazepine, 99% diclofe-
nac and 42% oxazepam (Pohl et al., 2018), suggesting that the
experimental setup served as a reasonable model for larger ozon-
ation facilities.
3.2. Carbamazepine embryotoxicity before and after ozone
treatment
To evaluate the effect of ozone treatment on carbamazepine,
diclofenac, and oxazepam embryotoxicity, lethal and sublethal ef-
fects were recorded before and after ozonation. Carbamazepine
exposure resulted in embryotoxicity at 144 hpf in the 50mg L1 and
100mg L1 treatment groups with 88% and 100% affected embryos
(dead and malformed combined) respectively (Bonferroni adjusted
Fisher's exact test p< 0.001, Fig. 3a). The 50mg L1 group consisted
of 8 malformed embryos (side-lying with or without scoliosis) out
Table 1
Nominal and measured treatment concentrations (mg L1, NA¼ not analyzed, LOQ¼ limit of quantiﬁcation).
Chemical Nominal concentration (mg L1) Measured concentration (mg L1) Measured in % of nominal concentration LOQ (mg L1)
Carbamazepine 0 <LOQ 100 3.3e6
25 17 68
50 30 60
100 50 50
Diclofenac 0 <LOQ 100 4.0e6
3.8 NA NA
7.5 7.4 99
15 15 100
Oxazepam 0 <LOQ 100 3.0e6
0.10 0.09 90
1.0 0.84 84
10 7.0 70
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of in total 16 while 14 out of in total 16 embryos were dead in the
100mg L1 treatment at 144 hpf (Supplementary Data Table S2).
Furthermore, carbamazepine exposure signiﬁcantly reduced the
heart rate (ANOVA p¼ 0.005364, Dunnett's p< 0.01) at 48 hpf in
the highest treatment group (Fig. 4a). Hatching time showed a
trend of delay with increasing carbamazepine concentration, and in
the highest treatment group (100mg L1) all embryos were dead
prior to hatching (Fig. 5a). The pre-hatching mortalities were pre-
ceded by the incidence of pericardial and yolk-sac edemas recorded
at 48 hpf. The swimming activity assay at 144 hpf showed a
reduction in swimming distance (in the 50mg L1 treatment
group) during both light and dark periods, albeit non-signiﬁcant
likely due to poor replication (n¼ 2 unaffected larvae,
Supplementary Data Fig. S2).
Carbamazepine toxicity during zebraﬁsh embryo development
has been investigated in previous studies, with results in line with
the present study. Beker van Woudenberg et al. (2014) reported
that the most sensitive endpoint observed in zebraﬁsh embryos
was a delayed onset of hatching (72 hpf, EC50 45.5mg L1) and
pericardial edema (96 hpf, EC50 52mg L1). Furthermore, larvae
exposed to 43 and 57mg L1 carbamazepine were hypoactive
during dark periods (Beker van Woudenberg et al., 2014). Exposure
to carbamazepine (1 mg L1) has also been reported to increase
body length and cause behavioral effects in zebraﬁsh embryos
(Qiang et al., 2016). Besides early development toxicity in zebraﬁsh,
carbamazepine has also been shown to cause reproductive toxicity
in exposed (100 mg L1) sexually mature Chinese rare minnows
(Gobiocypris rarus; Yan et al. (2018)).
Ozonation of carbamazepine increased toxicity in all endpoints
in the present study. The lowest observed effect concentration
(LOEC) of carbamazepine based on percent affected at 144 hpf was
reduced from the medium concentration (50mg L1) to the lowest
(25mg L1) following ozonation for 10min (Fig. 3a). The increased
toxicity in the lowest carbamazepine concentration ozonated
10min was mainly manifested by side-lying (due to lack of swim
bladder inﬂation) at 144 hpf. The sublethal endpoints heart rate
(Fig. 4a) and hatching time (Fig. 5a) followed the same pattern of
increased toxicity following 10min carbamazepine ozonation.
Ozonation for 10min caused reduced heart rate in the lowest
(25mg L1) concentration treatment group (ANOVA p¼ 6.79e16,
Dunnett's p< 0.001). The larvae swimming activity assay revealed a
hypoactivity response in individuals exposed to ozonated carba-
mazepine (Supplementary Data Fig. S2). Altogether, these results
indicate that carbamazepine ozonation produced toxic OBPs
implying reduced embryo survivability. In a cell viability test
(Pseudomonas sp. Strain KSH-1), higher toxicity was recorded after
Fig. 1. Ozone removal efﬁciency of (A) carbamazepine, (B) diclofenac and (C) oxazepam after 0, 1 and 10-min ozonation. The lowest concentration of diclofenac (3.8mg L1 nominal
concentration) was not analyzed (NA).
Fig. 2. Measured concentrations (mg L1) of carbamazepine (-) and suspected carbamazepine OBPs carbamazepine-10,11-epoxide (þ); 10,11-dihydrocarbamazepine (:); 10,11-
dihydro-10-hydroxycarbamazepine (C), and oxcarbazepine (⊠) in the different test solutions (0, 25, 50, 100 mg L1 nominal concentrations) in dependence of the ozonation
dosage.
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10 and 30min ozonation time, which then was removed after 60
and 120min ozonation (Dwivedi et al., 2018). Ozonated carba-
mazepine has also been shown to increase cytotoxicity and geno-
toxicity in cell based in vitro test systems (Han et al., 2018). OBPs, in
particular, carbamazepine-10,11-epoxide, are more toxic than the
parent compound (LC50: 0.2mg kg1 and 1.1mg kg1, respectively)
to the macroinvertebrate Chironomus riparius (Heye et al., 2016). To
our knowledge, there are no other studies reporting zebraﬁsh
embryotoxicity of ozonated carbamazepine to date.
3.3. Carbamazepine OBP formation
Four carbamazepine OBPs were possible to analyze being
commercially available as reference standards. Cbz-Ep was detec-
ted in all ozonated carbamazepine samples, with the largest
amount (3.4mg L1) formed in the highest carbamazepine con-
centration ozonated for 1min (Fig. 2). It is possible that Cbz-Ep was
one major driver of increased toxicity of ozonated carbamazepine
in the present study, since its concentration increased by ozone
treatment (Fig. 2). The main metabolic pathway of carbamazepine
in the human liver starts with the CYP3A4-mediated formation of
Fig. 3. Affected (% out of 16 replicates) zebraﬁsh embryos at 144 hpf. Signiﬁcant dif-
ferences (***: p < 0.001) between treatments and control were detected for carba-
mazepine and diclofenac (Bonferroni adjusted Fisher's exact test).
Fig. 4. Heart rate (heartbeats/minute, mean ± sd) in zebraﬁsh embryos at 48 hpf.
Statistical analysis was performed using one-way ANOVA and Dunnett's post-hoc test
(**: p < 0.01, ***: p < 0.001).
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Cbz-Ep, the main therapeutically active carbamazepine metabolite
(Breton et al., 2005). Cbz-Ep has also been shown to be formed in
adult wild Rio de la Plata onesided livebearer (Jenynsia multi-
dentata) exposed to carbamazepine, illustrating the concern of
biotransformation and potential biological effects occurring in non-
target species (Valdes et al., 2016).
The second most abundantly detected carbamazepine OBP in
the present study was Di-Cbz. All carbamazepine treatment sam-
ples, ozonated and not ozonated, contained concentrations of Di-
Cbz exceeding LOQ (Fig. 2). Concentrations of Di-Cbz in non-
ozonated samples increased with increasing concentration of car-
bamazepine; 0.081mg L1 in the lowest concentration (Fig. 2b),
0.15mg L1 in the medium concentration (Fig. 2c), and 0.27mg L1
in the highest concentration (Fig. 2d). This could implicate the ac-
tion of some metabolizing process independent of ozonation. The
carbamazepine metabolite concentration has been shown to in-
crease in some cases following treatment in conventional sewage
treatment plants, presumably by biotic and abiotic processes
(Leclercq et al., 2009). In the present study, ozonation for 1min
further increased concentrations of Di-Cbz. Prolonging ozonation
dosage to 10min did, however, decrease concentrations of Di-Cbz
in the lowest and medium carbamazepine concentrations. Mean-
while, its concentration in the highest carbamazepine concentra-
tion continued to increase, capping at 1.1mg L1. This may partly be
explained by the chemical stability of Di-Cbz or the possibility that
the higher ozone dosage was enough to further eliminate Di-Cbz in
the two lower carbamazepine concentrations, but not the highest.
DiOH-Cbz was only detected (0.017mg L1) in the highest car-
bamazepine concentration ozonated for 1min (Fig. 2). DiOH-Cbz is
a carbamazepine metabolite mainly formed by hepatic metabolism
of Cbz-Ep and Ox-Cz (Breton et al., 2005). Ox-Czwas not detected in
any sample, and thus likely not formed by carbamazepine
ozonation.
3.4. Diclofenac embryotoxicity before and after ozone treatment
Diclofenac exposure (7.5 and 15mg L1 nominal concentrations)
caused pericardial- and yolk-sac edemas, as well as restricted sys-
temic circulation, at 48 hpf (Bonferroni adjusted Fisher's exact test
p< 0.001). Furthermore, 15mg L1 exposure reduced heart rate
(ANOVA p¼ 3.081e16, Dunnett's p< 0.001) by ~50% (Fig. 4b).
These responses subsequently gave rise to 100% mortalities at 144
hpf (Fig. 3b). The lowest concentration treatment group
(3.8mg L1) did not exhibit a signiﬁcant proportion of affected (3
malformed and 1 dead embryo, 25% affected) at 48 hpf, yet caused
81% affected embryos (Bonferroni adjusted Fisher's exact test
p< 0.001) at 144 hpf (Fig. 3b). Hatching was not delayed by diclo-
fenac exposure in the two lower exposure groups but the 15mg L1
treatment group failed to hatch due to 100% pre-hatch mortalities
(Fig. 5b). No behavioral effects were detected for diclofenac in the
swimming activity assay (Supplementary Data Fig. S3). Diclofenac
exposure at much lower concentrations (5 mg L1) has previously
been shown to delay hatching time, reduce swimming velocity and
distance during light conditions, and reduce spontaneous coiling
motions in zebraﬁsh embryos (Xia et al., 2017).
Diclofenac toxicity was conclusively reduced following ozona-
tion. Non-ozonated diclofenac toxicity was predominately man-
ifested by pericardial edemas and reduced heart rate at 48 hpf,
which was abolished completely after 10min ozonation (Fig. 3b,
Supplementary Data Table S2). The percentage number of affected
embryos exposed to the lowest diclofenac concentration
(3.8mg L1) at 144 hpf, which amounted to 81% in non-ozonated
group, was reduced to control group level after 1min ozonation
(Fig. 3b). Diclofenac ozonated for 10min did not produce any
toxicity in any endpoint. Likewise, ozonation led to a reduction of
diclofenac toxicity in a Microtox (Vibrio ﬁscheri NRRL B-11177
strain) in vitro study (Coelho et al., 2009). There are, to our current
knowledge, no previous studies on zebraﬁsh embryotoxicity of
diclofenac post-ozonation.
3.5. Oxazepam embryotoxicity before and after ozone treatment
Oxazepam did not cause toxic responses in any recorded lethal
or sublethal endpoint in the present study except for larvae loco-
motion. Ozonation of the highest oxazepam concentration
(10mg L1) at 10min caused hypoactivity during dark conditions
(ANOVA p¼ 0.006535, Dunnett's p< 0.05) in larvae (Fig. 6c). This
concentration is much higher than concentrations known to pro-
duce behavioral effects (increased boldness) in wild perch (Perca
ﬂuviatilis; Brodin et al., 2013). Oxazepam is a GABAA receptor acti-
vator, an anxiolytic benzodiazepine which gives rise to GABAergic
behavioral modiﬁcations. Since larvae activity is induced by dark
periods (an anxiety-like response) in the larvae swimming activity
assay, the hypoactivity illustrated in this and other studies may be
explained by an anxiolytic mode of action (Ali et al., 2011; MacPhail
et al., 2009). One possibility of this response could be the formation
of OBPs potentiating the anxiolytic properties of oxazepam in the
exposed zebraﬁsh embryos. Oxazepam exposure (10mg L1) of
larval Japanese medaka (Oryzias latipes) decreases swimming ac-
tivity during dark periods (Chiffre et al., 2016). The zebraﬁsh em-
bryo may be less sensitive than the Japanese medaka larvae in this
respect which could be a matter of species or life stage differences.
Fig. 5. Hatching time (hpf, mean ± sd) of zebraﬁsh embryos exposed to (a) carba-
mazepine and (b) diclofenac (oxazepam hatching time was not recorded due to
technical issues). Statistical analysis was performed using one-way ANOVA and Dun-
nett's post-hoc test (*: p < 0.05, **: p < 0.01).
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The present study indicates that ozonation of oxazepam at high
concentrations (10mg L1) has the potential to produce effects on
larval ﬁsh swimming behavior, which could potentially lead to ef-
fects on subsequent survivability due to impaired escape response.
3.6. Ozonation as an additional sewage treatment step
The development of safe and effective novel sewage treatment
technologies relies on mitigating any toxicity arising in the post-
treated efﬂuent. A zebraﬁsh embryotoxicity test, similar to the
one conducted in the present study, has previously been used to
show increasing toxicity of STP efﬂuent following ozonation (Wigh
et al., 2015). Ozone can produce aldehydic compounds in sewage
efﬂuents, being acutely toxic to early life-stage ﬁsh (Yan et al.,
2014). The highly toxic compound bromate is also formed in
wastewater following ozonation which poses a challenge
(Soltermann et al., 2017). Likewise, we have observed that phar-
maceuticals in particular carbamazepine, may becomemore toxic
to zebraﬁsh embryos after ozonation. However, the pharmaceutical
concentrations used as treatments in the current study were
around ﬁve-fold higher than normally found in environmental
matrices. Yet chronic exposure at lower, closer to environmentally
relevant, concentrations of e.g. diclofenac can ultimately give rise to
adverse effects in ﬁsh (Mehinto et al., 2010). Therefore, the increase
of toxicity from formed carbamazepine OBPs, and oxazepam should
warrant caution.
The present study shows that pharmaceutical OBPs are impor-
tant to control for in post-ozonated efﬂuents. Post-ozonation ﬁlters
have been suggested as a method for removing OBPs and thereby
preventing toxicity (Stalter et al., 2010). However, since carba-
mazepine has been shown to bio-transform into potentially more
toxic metabolites in bioactive ﬁlters (Kaiser et al., 2014), a combi-
nation of ozonation and bioﬁltration may ultimately lead to toxicity
abatement of the efﬂuent (de Wilt et al., 2018). There are also
additional treatment steps which can improve the removal efﬁ-
ciency of ozone, e.g. addition of hydrogen peroxide escalating OH-
Fig. 6. Swimming activity (distance moved over time) in zebraﬁsh embryos exposed to oxazepam ozonated 0 min (a), 1 min (b) and 10 min (c). The left panel shows total distance
moved per minute (mean) and the right panel shows mean total distance moved during dark and light conditions (mean ± sd). Statistical analysis was performed using one-way
ANOVA and Dunnett's post-hoc test (*: p < 0.05), where total distance moved during darkness and light for each larva was considered an individual replicate.
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radical formation (von Gunten, 2003). These ozonation ‘add-ons’
were not utilized in the present study and could affect toxicity
outcome in further studies.
4. Conclusions
We have presented that ozonation was effective in removing
carbamazepine and diclofenac fromwater while leaving oxazepam
mostly intact. The toxicity resulting from the ozone treatment was
reduced for diclofenac but increased for carbamazepine and oxaz-
epam. The toxicity increase may be explained by OBP formation in
the case of carbamazepine, where three screened carbamazepine
OBPs where detected in post-ozonation samples. Oxazepam
ozonation gave rise to behavioral effects possibly explained by
increased bioavailability or potency. Further investigations are
needed to prove the cause of the increased toxicity and ﬁnd the
most problematic OBP in order to prevent ozone-mediated toxicity
in post-ozonated efﬂuents before release into the recipient.
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Table S1. Water parameters of the treatments directly post-ozonation 
Chemical Concentration Ozone dosage pH Conductivity Dissolved oxygen (%) 
Carbamazepine 0 0 8.3 430 94 
  
1 8.2 429 94 
  
10 8.3 431 93 
 
25 0 8.2 434 94 
  
1 8.2 434 94 
  
10 8.2 435 96 
 
50 0 8.2 440 94 
  
1 8.2 435 93 
  
10 8.2 436 94 
 
100 0 8.3 442 94 
  
1 8.2 435 94 
  
10 8.1 439 94 
Diclofenac 0 0 8.2 444 94 
  
1 8.2 444 94 
  
10 8.2 450 94 
 
3.8 0 8.3 450 94 
  
1 8.2 448 96 
  
10 8.1 451 94 
 
7.5 0 8.2 451 96 
  
1 8.2 449 94 
  
10 8.0 453 93 
 
15 0 8.2 448 94 
  
1 8.3 452 94 
  
10 8.0 455 93 
Oxazepam 0 0 8.2 430 94 
  
1 8.2 428 94 
  
10 8.2 429 94 
 
0.1 0 8.2 427 94 
  
1 8.2 428 96 
  
10 8.2 428 94 
 
1.0 0 8.3 431 96 
  
1 8.2 430 94 
  
10 8.2 430 93 
 
10 0 8.2 429 94 
  
1 8.2 428 94 
  
10 8.2 429 94 
 
 
 
 
Table S2. Lethality and malformation counts at 24 hpf, 48 hpf and 144 hpf for the exposure studies. 
Chemical Concentration Ozone dosage Assessed individuals (n, dead/malformed/normal) 
   
24 hpf 48 hpf 144 hpf 
Carbamazepine 0 0 0/0/16 0/0/16 0/0/16 
  1 0/0/16 0/0/16 0/0/16 
  10 0/0/16 0/0/16 0/0/16 
 25 0 0/0/16 0/0/16 0/1/15 
  1 0/0/16 0/0/16 0/1/15 
  10 0/0/16 0/1/15 1/9/6 
 50 0 2/0/14 2/0/14 6/8/2 
  1 1/0/15 1/0/15 1/9/6 
  10 0/0/16 0/3/13 16/0/0 
 100 0 1/0/15 1/1/14 14/2/0 
  1 0/0/16 0/5/11 15/1/0 
  10 0/0/16 16/0/0 16/0/0 
Diclofenac 0 0 1/0/15 1/0/15 1/0/15 
  1 1/0/15 1/0/15 2/0/14 
  10 0/0/16 0/0/16 0/0/16 
 3.8 0 1/0/15 1/3/12 9/4/3 
  1 1/0/15 1/1/14 2/0/14 
  10 1/0/15 1/0/15 1/0/15 
 7.5 0 0/0/16 0/14/2 16/0/0 
  1 0/0/16 0/10/6 15/0/1 
  10 0/0/16 0/0/16 0/1/15 
 15 0 1/0/15 2/14/0 16/0/0 
  1 0/0/16 0/16/0 16/0/0 
  10 0/0/16 0/3/13 0/1/15 
Oxazepam 0 0 0/0/16 0/0/16 0/1/15 
  1 0/0/16 0/0/16 0/2/14 
  10 0/0/16 0/0/16 0/0/16 
 0.1 0 0/0/16 0/0/16 0/2/14 
  1 0/0/16 0/0/16 0/2/14 
  10 0/0/16 0/0/16 0/0/16 
 1.0 0 0/0/16 0/0/16 0/0/16 
  1 0/0/16 0/0/16 0/1/15 
  10 0/0/16 0/1/15 1/2/13 
 10 0 0/0/16 0/0/16 0/3/13 
  1 0/0/16 0/0/16 1/4/11 
  10 0/0/16 0/0/16 0/4/12 
 
 Figure S1. Ozone concentrations (mg O3/L) in the ozonation vessel (250 mL dechlorinated carbon 
filtered water at ±25 °C) sampled at 1, 5, 10, 30, 60, and 135 minutes after initiation of the ozonation 
process. The filled diamonds represent the low (1 minute) and high (10 minutes) ozonation dosages 
which were applied to the pharmaceutical solutions.  
 Figure S2. Locomotor activity (distance moved over time) in zebrafish exposed to carbamazepine ozonated 0 
minutes (A), 1 minute (B) and 10 minutes (C). The left panel show mean total distance moved per minute and 
the right panel shows mean total distance moved during dark and light conditions. Larvae displayed 
hypoactivity during light conditions after exposure to 50 mg/L carbamazepine ozonated during 1 minute (B; 
ANOVA p = 0.05709, Dunnett’s p<0.05) and 25 mg/L during 10 minutes (C; ANOVA p = 0.01003, Dunnett’s 
p<0.05). 
 
 
 Figure S3. Locomotor activity (distance moved over time) in zebrafish exposed to diclofenac ozonated 0 
minutes (A), 1 minute (B) and 10 minutes (C). The right panel show mean total distance moved per minute and 
the right panel shows mean total distance moved during dark and light conditions.  
 Figure S4. Chromatograms for the target compounds. 
 
Recoveries. The recovery of the target compounds was studied by spiking control ozonated water with 
a mixture of the target compounds. The average recovery of target compounds was 100±5% (recovery 
was tested for one concentration levels, duplicates). 
The average limit of quantification for the target compounds were: Oxazepam 0.003 mg/L, diclofenac 
0.004 mg/L, carbamazepine 0.003 mg/L, 10,11-dihydro-10-hydroxycarbamazepine 0.008 mg/L, 
carbamazepine-10,11-epoxide 0.004 mg/L, oxcarbazepine 0.003 mg/L and 10,11-
dihydrocarbamazepine 0.004 mg/L. 
 
 
 
 
 
 
 
 
  
Figure S5. Representative images of observed embryo malformations. 
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ABSTRACT: Carbamazepine (CBZ) is an anticonvulsant medi-
cation with highly persistent properties in the aquatic environment,
where it has the potential to aﬀect nontarget biota. Because CBZ
and many other pharmaceuticals are not readily removed in
conventional sewage treatment plants (STP), additional STP
eﬄuent treatment technologies are being evaluated and imple-
mented. Whole eﬄuent ozonation is a prospective method to
remove pharmaceuticals such as CBZ, yet knowledge on the
toxicity of CBZ ozonation byproducts (OBPs) is lacking. This
study presents, for the ﬁrst time, in vivo individual and mixture
toxicity of four putative OBPs, that is, carbamazepine 10,11-
epoxide, 10,11-Dihydrocarbamazepine, 1-(2-benzaldehyde)-4-
hydro-(1H,3H)-quinazoline-2-one (BQM), and 1-(2-benzalde-
hyde)-(1H,3H)-quinazoline-2,4-dione (BQD) in developing zebra-
ﬁsh (Danio rerio) embryos. BQM and BQD were isolated from the ozonated solution as they were not commercially available. The
study conﬁrmed that the OBP mixture caused embryotoxic responses comparable to that of ozonated CBZ. Individual compound
embryotoxicity assessment further revealed that BQM and BQD were the drivers of embryotoxicity. OBP chemical stability in
ozonated CBZ water solution during 2 week dark storage at 22 °C was also assessed. The OBP concentrations remained over time,
except for BQD which decreased by 94%. Meanwhile, ozonated CBZ persistently induced embryotoxicity over 2 week storage,
potentially illustrating environmental concern.
1. INTRODUCTION
Pharmaceutical residues in sewage treatment plant (STP)
eﬄuents are increasingly studied as they are suspected to have
persistent and toxic properties in the aquatic environment.1
Carbamazepine (CBZ) is an anticonvulsant pharmaceutical
mainly prescribed to patients suﬀering from epilepsy and also
used to medicate symptoms of schizophrenia and bipolar
disorder.2 First synthesized in 1953 by Swiss chemists, CBZ
has become widely used and it is included in the World Health
Organization’s (WHO) Model List of Essential Medicines.3,4
The mode of action for CBZ is through sodium channel
blocking by the therapeutically active carbamazepine 10,11-
epoxide (CBZ-EP) metabolite,5,6 reducing synaptic activity in
the central nervous system.7 About 13% of the ingested CBZ
dose is excreted in unmetabolized form, mainly fecal
excretion.8
The overall removal eﬃciency of CBZ in conventional STPs
is only about 2%.9 CBZ is consequently detected in surface
water environments in the ng to μg L−1 concentration
range.10−12 CBZ is furthermore not prone to photodegrada-
tion.13 Mass balance-based models have suggested that
approximately 55 metric tons of CBZ has accumulated in the
Baltic Sea since its introduction to the market because of its
persistent properties.9 Bioaccumulation of CBZ has been
observed in, for example, bivalves14 and ﬁsh.15 Adverse eﬀects
resulting from CBZ exposure at concentrations proximal to
environmental levels have been demonstrated in aquatic
invertebrates.16 Fish are however considerably less sensitive
to CBZ, with acute and chronic eﬀect concentrations reported
in the 10−100 mg L−1 range.16−18 Nevertheless, the constant
release of CBZ and many other persistent and bioaccumulative
pharmaceuticals warrants attention and could well be hazard-
ous to ﬁsh because of mixture eﬀects in polluted areas.19
Novel technologies with the aim to improve STP removal
eﬃciencies of pharmaceuticals and other micropollutants are
being investigated.20 Studies on ozonation as a tertiary STP
eﬄuent treatment technology have shown that CBZ can be
removed by more than 90%.21−23 However, ozonation of CBZ
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can cause increased toxicity as observed in zebraﬁsh (Danio
rerio) embryos,17 and cell-based in vitro assays.24,25 Because
the CBZ molecule has a high degree of reactivity with ozone,
several intermediaries, that is, ozonation byproducts (OBPs),
are created. Two key OBPs, 1-(2-benzaldehyde)-4-hydro-
(1H,3H)-quinazoline-2-one (BQM) and 1-(2-benzaldehyde)-
(1H,3H)-quinazoline-2,4-dione (BQD), have been identiﬁed
previously.26−28 Besides, 10,11-Dihydrocarbamazepine (DI-
CBZ) and the therapeutically active CBZ metabolite CBZ-EP
have been quantiﬁed after ozonation of CBZ.17
There are considerable knowledge gaps regarding the
identities and toxic potential of pharmaceutical OBPs. This
study therefore aimed at evaluating individual and mixture
toxicities of BQM, BQD, CBZ-EP, and DI-CBZ, which are
formed following CBZ ozonation. Because BQM and BQD
were unavailable as analytical standards at the time of the
study, we proceeded to isolate them from ozonated CBZ. We
hypothesized that one or more of these four OBPs could be
the main drivers of ozonated CBZ embryotoxicity previously
reported in zebraﬁsh by us.17 Furthermore, the toxicity and
composition of OBPs in STPs may change after release into
the aquatic environment because of diﬀerences in the stability
of the OBPs. We therefore sought to establish whether induced
CBZ embryotoxicity postozonation, as well as OBP compo-
sition, would persist after storage of the OBPs in a water
solution for up to 2 weeks.
2. MATERIALS AND METHODS
2.1. Chemicals. CBZ (CAS number 298-46-4, purity ≥
98%), CBZ-EP (CAS number 36507-30-9, purity ≥ 98%),
10,11-Dihydro-10-hydroxycarbamazepine (DIOH-CBZ, CAS
number 29331-92-8, purity ≥ 99%), and DI-CBZ (CAS
number 3564-73-6, purity ≥ 99%) were purchased from
Sigma-Aldrich (Sweden). An internal standard of CBZ (D10)
was acquired from Sigma-Aldrich (Sweden). Ethyl 3-amino-
benzoate methanesulfonate salt (MS-222) was purchased from
Sigma-Aldrich (Sweden). Ultrapure water was produced by a
Milli-Q Advantage ultrapure water puriﬁcation system and
ﬁltered through a 0.22 μm Millipak express membrane and an
LC-Pak polishing unit (Merk Millipore, Billerica, MA). Liquid
chromatography−mass spectrometry (LC/MS) grade acetoni-
trile, methanol, and ammonium acetate were purchased from
Sigma-Aldrich (St. Luis, MO, USA).
2.2. Ozonation of CBZ. A CBZ stock solution (25 mg L−1
nominal concentration) was prepared by dissolving CBZ in
carbon-ﬁltered tap water (22 °C, pH: 8.38 ± 0.02,
conductivity: 453 ± 20 mS cm−1, alkalinity: 8 °dH, dissolved
O2: 95 ± 4%) in a glass Erlenmeyer ﬂask. Two 250 mL
aliquots of CBZ were thereafter distributed to Erlenmeyer
ﬂasks. One aliquot was ozonated for 10 min (0.29 mg L−1 peak
dissolved O3) using a lab-scale ozone generator (described in
detail in the report by Pohl et al.17). Dissolved O3
concentrations were measured by the LCK310 Ozone cuvette
test (0.05−2 mg L−1 measurement range) in a DR 3900
spectrophotometer (Hach, Loveland, Colorado, United
States). A 60 mL grab sample was collected from the ozonated
stock solution in a polypropylene centrifuge tube, snap-frozen
in liquid nitrogen, and stored at −80 °C for subsequent
chemical analysis and transformation product isolation. The
second CBZ aliquot was not ozonated. The Erlenmeyer ﬂasks
were thereafter stoppered and wrapped in aluminum foil for
stability testing (Section 2.6).
2.3. Isolation of BQM and BQD. BQM and BQD were
isolated from the ozonated CBZ solution for embryotoxicity
testing. The grab sample (60 mL) was preconcentrated using
solid-phase extraction (SPE) (Oasis HLB Plus short cartridge,
225 mg sorbent per cartridge, 60 μm particle size). The
cartridges were activated with 5 mL methanol, rinsed with 5
mL Milli-Q water, and then dried for 1 min under vacuum.
The samples (2 × 30 mL) were loaded onto two SPE
cartridges and eluted with 2 × 5 mL methanol, and the volume
was then reduced to 1 mL using a gentle stream of nitrogen
gas.
Semipreparative LC was conducted on a Shimadzu LC-
system consisting of two pumps (LC-10 ADvp), autoinjector
(SiL-HTC), and a UV-detector (SPD-10 A). The separation
was achieved on a reversed-phase C18 column (Vydac C18
218TP510) at a ﬂow rate of 3 mL min−1. The mobile phase
consisted of acetonitrile and Milli-Q water. The OBPs were
eluted isocratically for 1 min with 15% acetonitrile followed by
an increase in the acetonitrile content up to 80% over 15 min,
after which it was lowered to 20% during 1 min. An
equilibration time of 4 min was used between each injection.
The UV-detector was set to operate at a wavelength (λ) of
285 nm. The two major peaks were identiﬁed according to the
wavelengths speciﬁed by McDowell et al. (2005)28 and
collected between the retention times of 8.60−9.20 (BQM)
and 9.37−9.80 min (BQD). The injection of 100 μL was
repeated 10 times. The peaks were collected in 25 mL jars. The
solvent in each jar was let to evaporate in a fume hood at room
temperature (22 °C) to dryness. The two isolated peaks were
each transferred into an 18 mL glass test tube with a total of 10
mL methanol (rinsed 3 times in total). For BQM and BQD
quantiﬁcation in the ﬁnal stock solutions, the extinction
coeﬃcient (ε) of CBZ was measured at 248 nm, and for the
two OBP peaks the extinction coeﬃcients were taken from
McDowell et al. (2005)28 (Table 1). The Beer−Lambert law
was used to calculate the concentrations of BQM and BQD 1.
ε= × ×A C l (1)
where A is the absorbance, ε the extinction coeﬃcient, C the
concentration, and l the length of the cuvette. Chemical
concentration measurements indicated that a total stock
solution content of 0.57 mg BQM, and 0.16 mg BQD were
formed and isolated. The purity was >98% for BQM and >93%
for BQD, based on the absorbance (Figure 1). The two
isolated compounds (BQM and BQD) were used for
subsequent embryotoxicity testing and as standard solutions
Table 1. Retention Time (RT), Molecular Mass (M), Extinction Coeﬃcient (ε), Wavelength (λ), Absorption (A),
Concentration (C), and Amount (m) of CBZ and Isolated OBPs
compound RT (min) M (g mol−1) ε λ (nm) A C (mmol L−1) m (mg)
CBZ 10.7 236 11900a 284 594998 0.1059 1.50
BQM 8.8 250 35000b 206 1876920 0.2272 0.57
BQD 9.4 266 28000b 219 394158 0.0596 0.16
aMeasured at 248 nm. bMcDowell et al. (2005).28
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for the determination of the actual concentrations in the
toxicity test solutions.
2.4. Exposure Solutions. CBZ-EP and DI-CBZ exposure
solutions were prepared from analytical grade powder mixed
directly in tap water in Erlenmeyer ﬂasks. BQM and BQD
exposure solutions were prepared from isolated peaks solved in
methanol. Aliquots of methanol-containing BQD and BQM,
distributed in Erlenmeyer ﬂasks, were allowed to fully
evaporate inside a fume hood at 22 °C before tap water was
added. All exposure solutions were thoroughly vortexed until
compounds were completely dissolved. A mixture solution of
BQM, BQD, CBZ-EP, and DI-CBZ was made by letting BQM
and BQD methanol stock solutions evaporate before adding
CBZ-EP and DI-CBZ exposure solution. All exposure solutions
were prepared in carbon-ﬁltered aerated tap water (pH: 8.38 ±
0.02, conductivity: 453 ± 20 mS cm−1, alkalinity: 8 °dH,
dissolved O2: 95 ± 4%). The same water was also used as a
control treatment in each test. Physiochemical properties of
each exposure solution did not deviate from that of tap water
control.
2.5. Zebraﬁsh Maintenance and OBP Embryotoxicity
Tests. Zebraﬁsh embryotoxicity test (ZFET) assays were
performed under controlled ambient conditions (12:12 h light
cycle, 26 ± 1 °C air temperature) according to previous
methodology described in the report by Pohl et al.17 Adult
laboratory-bred zebraﬁsh were initiated to spawn directly
before each exposure study (9 am to 11 am). Spawning was
induced by placing ﬁsh (∼5♂, ∼5♀) in stainless steel spawning
cages (5 mm mesh size) placed inside 10 L aquariums in the
morning before lights were turned on at 9 am. Eggs collected
from the spawning group displaying the highest fertilization
success rate and the lowest proportion of abnormalities and
coagulation were selected for ZFET.
The embryo exposure tests were static (the solutions were
not changed during the test) and began ∼3 h postfertilization
(hpf) and continued until 144 hpf. Fertilized eggs were placed
individually in 250 μL test solution (n = 16 per treatment) in
round-bottomed 96-well microplates which then were covered
by Paraﬁlm M (Bemis Company, United States). During the
exposure, heart rate (beats per min) was recorded at 48 hpf by
manual counting in a stereomicroscope. Time until hatching
(h) was assessed by automated photography (Canon EOS
500D) between 48 and 144 hpf (one photo per h). The
proportion of malformations and lethality (expressed as %
aﬀected) was recorded at 144 hpf. After completion of the
exposure test, the embryos were euthanized by exposure to a
high dose of MS-222 (1 g L−1).
2.6. Ozonated CBZ Stability and Embryotoxicity
Tests. Aliquots (250 mL) of CBZ, ozonated CBZ, and
control water were stored in the dark at room temperature (22
°C) for 2 weeks (336 h) in stoppered Erlenmeyer ﬂasks
wrapped in aluminum foil. Samples were collected from the
three aliquots at 0, 1, 24, 168, and 336 h. One subset of
samples (n = 3, v = 2 mL) were collected and stored in a
freezer (−20 °C) for chemical analysis and another sample (n
= 1, v = 40 mL) was used for zebraﬁsh embryo exposure tests.
The exposure tests (conducted as described in Section 2.5)
commenced directly after sampling at the ﬁve storage time-
points. The proportion of aﬀected (dead and malformed)
embryos at 144 hpf was the only assessed endpoint because of
time and logistical reasons, and as it was shown to be as
sensitive as the other endpoints measured in our previous
study.17
2.7. Chemical Analysis. The water samples were collected
in triplicates from all exposure solutions at the start of each
embryotoxicity test and kept frozen until chemical analysis
(−20 °C). The samples were ﬁltered using a regenerated
cellulose syringe ﬁlter (0.22 μm pores) and spiked with the
internal standard of CBZ (D10). The samples were analyzed
using liquid chromatography tandem-mass spectrometry (LC−
MS/MS) and a triple-stage quadrupole MS/MS TSQ Quantiva
(Thermo Fisher Scientiﬁc, San Jose, CA, USA). An Acquity
UPLC BEH-C18 column (Waters, 100 mm × 2.1 i.d., 1.7 μm
particle size from Waters Corporation, Manchester, UK) was
used as an analytical column. The injection volume was 10 μL
for all samples. Heated electrospray ionization was used to
ionize the target compounds. The spray voltage was set to
static: positive ion (V) 3500.00. Nitrogen (purity > 99.999%)
was used as a sheath gas (50 arbitrary units), auxiliary gas (15
arbitrary units), and sweep gas (2 arbitrary units). The
vaporizer was heated to 400 °C and the capillary to 325 °C.
Two selected reaction monitoring transitions were monitored
for all analytes (Table S1). Data were evaluated using
TraceFinder 3.3 software (Thermo Fisher Scientiﬁc, San
Jose, CA, USA).
The internal standard method was used for the target
compound quantiﬁcation. The performance of the method was
assessed concerning its linearity, limit of quantiﬁcations
(LOQs), relative recovery, precision, blanks, and matrix eﬀect.
The linearity of the calibration curve was tested in the range
from 0.001 to 10 mg L−1. The calibration curve was measured
twice, at the beginning and at the end of the sequence to check
instrumental stability. The calibration was prepared in Milli-Q
water. LOQs were calculated as half of the lowest calibration
point in the calibration curve where the relative standard
deviation of the average response factor was <30%. The peak
area corresponding to this concentration was used to calculate
LOQ for each individual compound in each sample. The
Figure 1. High performance liquid chromatography chromatogram of
(a) peak 1 (BQM, 206 nm) and (b) peak 2 (BQD, 219 nm) after
isolation.
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precision of the method was evaluated by the repeatability of
the study. For this purpose, duplicates were conducted for
every sample. The matrix eﬀect was assessed for each
compound, and corrections for ion suppression or enhance-
ment were accomplished using matrix-matched standards.
Matrix-matched standards were prepared from the ozonated
water sample that was spiked with internal standard and native
compounds at concentration levels of 0.01 and 0.1 mg L−1,
respectively. The matrix eﬀect was evaluated as the diﬀerence
between the matrix-matched standards’ relative response factor
and the average relative response factor obtained from the
calibration curve. Quality control was conﬁrmed by analysis of
blank samples (Milli-Q and tap water) to assure that target
analytes were not introduced from sampling or laboratory
procedures and sample handling. No target analytes were
detected in blank samples.
2.8. Statistical Analysis. R 3.6.0 software with a RStudio
version 1.1.463 interface was used for statistical analysis.29,30
The R package ggplot was used for data plotting.31 Continuous
data (i.e., heart rate and time until hatching) was checked and
conﬁrmed for normality and analyzed by one-way ANOVA
with Dunnett’s post hoc test.32 Nonparametric data (i.e.,
proportion of aﬀected embryos) was analyzed by Bonferroni-
adjusted Fisher’s exact test. A p-value of p < 0.05 was
considered as a signiﬁcantly deviating eﬀect as compared to the
control in the statistical tests.
3. RESULTS AND DISCUSSION
3.1. CBZ Ozone Removal Eﬃciency and OBP
Formation. The CBZ molecule is prone to ozone degradation
and will produce several intermediary OBPs (Figure 2). The
present study was initiated by establishing the ozone removal
eﬃciency of 17.5 mg L−1 CBZ ozonated 10 min in a
laboratory-scale ozonation reactor (0.29 mg L−1 peak dissolved
O3 concentration). The CBZ concentration was reduced by
82% following ozone treatment, from 17.5 to 3.1 mg L−1. OBP
formation (i.e., BQM, BQD, DI-CBZ, and CPZ-EP) from
ozonated CBZ was also quantiﬁed (Table 2). BQD was the
main product formed among the quantiﬁed OBPs, with a
concentration of 5.5 mg L−1. The second most formed product
was BQM (2.2 mg L−1). BQM and BQD were quantiﬁed using
isolated substances from ozonated CBZ as standards, meaning
that the measured concentrations should only be indicative of
actual concentrations. Previous studies have shown that BQM
is the major initial OBP but its concentration decreases with
increasing O3 concentration while BQD concentration, on the
contrary, will increase with increasing O3.
28,33,34 More
speciﬁcally, McDowell et al.28 measured BQD and BQM
concentrations in CBZ (0.85 mg L−1) ozonated for up to 2.5
min (2.4 mg O3 min
−1), with the two OBP reaching
approximately the same concentrations after 2.5 min. In the
present study we measured higher concentrations of BQD than
BQM after 10 min ozonation treatment (0.29 mg L−1 peak
dissolved O3), possibly because of the longer ozonation time
allowing increased BQD formation.
CBZ-EP reached a concentration of 0.5 mg L−1 following
ozonation. DI-CBZ concentrations were detected both in
preozonated (0.04 mg L−1) and postozonated (0.02 mg L−1)
CBZ samples. This could indicate DI-CBZ contamination in
the CBZ used in the present study, as the DI-CBZ content in
the preozonated CBZ solution was 0.02% (manufacturer
reported CBZ purity ≥98%). An additional putative OBP,
DIOH-CBZ, was included in the chemical analysis but not
detected in any sample.
The ozone removal eﬃciency in the present study (82%)
was lower than in our previous study, where an eﬃciency of
>99% was recorded.17 Moreover, the DI-CBZ concentration
following ozonation was lower in the present study (0.02 mg
L−1) than in our last study (0.2 mg L−1).17 The diﬀerence in
dissolved O3 concentration between the two studies could have
led to diverging oxidation kinetics aﬀecting CBZ removal and
byproduct formation.35,36 Dissolved O3 measurements in-
dicated that a higher O3 concentration was achieved in the
present study (0.29 mg peak dissolved O3 L
−1 after 10 min
ozonation) using the same ozone reactor set-up as in the
previous study (0.15 mg peak dissolved O3 L
−1 after 10 min
ozonation,17). The diﬀerence in O3 concentration could
perhaps be explained by the use of a higher-capacity diﬀusor
attached to the ozone generator. DI-CBZ formation has been
shown to be inversely related to O3 concentration,
17 which
could explain why we quantiﬁed less DI-CBZ in the present
study compared with our previous.
3.2. Toxic Eﬀects of Individual OBPs. The four CBZ
OBPs (i.e., BQM, BQD, CBZ-EP, and DI-CBZ) were tested
individually and in a mixture in ZFET assays. The toxicity
endpoint heart rate (beats min−1) at 48 hpf, time until
hatching (hpf), and proportion of aﬀected (% dead and
malformed) embryos at 144 hpf were measured (Figure 3).
Three concentrations were tested in each study (Table 2). The
single compound and mixture exposure concentrations were
produced based on the OBP concentrations measured in Pohl
et al.17 (for DI-CBZ and CBZ-EP) and the present study (for
BQM and BQD). The intention was to design concentration
ranges encompassing half (0.5×), equal (1×), and double (2×)
that of the total OBP concentration quantiﬁed after ozonation
of CBZ (Table 2). When comparing measured concentrations
in the ozonated water (intended concentrations) with those of
the 1× exposure solutions, DI-CBZ and BQM concentrations
corresponded fairly well (Table 2). However, the measured
concentrations for CBZ-EP and BQD in the 1× exposure
solutions deviated from the intended concentrations, being
about threefold higher for CBZ-EP and 2.5-fold lower for
BQD. These deviations were likely caused by dilution or
weighing errors. Besides, the fact that BQD was not stable
during storage at room temperature (Figure 4c) may have
added to the uncertainty of the analytical results for this OBP.
Exposure to BQM (Figure 3c) and BQD (Figure 3d) both
resulted in decreased heart rate and prolonged hatching time.
A clear concentration−response relationship was observed,
Figure 2. Proposed ozone-mediated degradation of CBZ, based on
Figure 2 in the publication by Hübner et al. (2014).27
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with the eﬀect increasing with higher concentrations of both
BQM and BQD. The proportion of dead and malformed
embryos at 144 hpf was above control group levels in the 2×
but not in the 1× concentrations of BQM or BQD. No eﬀects
in any endpoint were detected in the tested concentrations of
either CBZ-EP (Figure 3e) or DI-CBZ (Figure 3f). CBZ-EP
has been reported to be more toxic than CBZ to an aquatic
invertebrate.37 In the present study, however, CBZ-EP and DI-
CBZ concentrations at levels approximating that formed by
CBZ ozonation did not elicit toxicity.
3.3. Mixture Toxicity of OBPs. One of the central focuses
of the present study was to compare single compound and
mixture toxicity. The rationale for assessing the mixture was to
establish whether it would produce embryotoxic eﬀects as
observed in ozonated CBZ in our previous (Pohl et al.,17
Figure 3a) and present study (Figure 5a). Despite the
uncertainty about BQM and BQD concentrations in exposure
solutions after ozonation of CBZ in Pohl et al.17 (not screened
for), and the deviation of measured CBZ-EP and BQD
concentrations from the intended in the present study, the 1×
Table 2. Measured CBZ and OBP Concentrations (mg L−1, Mean ± Standard Deviation, NA = Not Analyzed, LOQ = Limit of
Quantiﬁcation)
Pohl et al.17 (17 mg L−1 CBZ
ozonated 10 min)
present study (17.5 mg L−1
CBZ ozonated 10 min)
single compound and mixture
exposure solutions
abbreviation 1× 1× 0.5× 1× 2×
LOQ
(mg L−1)
carbamazepine CBZ <LOQ 3.1 <LOQ <LOQ <LOQ 0.0025
carbamazepine 10,11-epoxide CBZ-EP 0.5 0.5 0.8 1.5 2.6 0.0024
10,11-Dihydrocarbamazepine DI-CBZ 0.2 0.02 0.1 0.2 0.4 0.0024
1-(2-benzaldehyde)-4-hydro-
(1H,3H)-quinazoline-2-one
BQM NA 2.2 0.8 1.8 3.5 0.0026
1-(2-benzaldehyde)-(1H,3H)-
quinazoline-2,4-dione
BQD NA 5.5 1.7 1.9 6 0.0019
mixture CBZ-EP 0.7 1.9 4.3 0.0024
DI-CBZ 0.1 0.2 0.5 0.0024
BQM 0.8 1.6 3.7 0.0026
BQD 1.5 2.6 7.7 0.0019
Figure 3. Embryotoxicity responses, that is, proportion of aﬀected (dead and/or malformed) embryo−larvae (%), heart rate (beats min−1, mean ±
sd), and time until hatching (hpf, mean ± sd) in zebraﬁsh exposed to (a) ozonated CBZ (adapted from Pohl et al.17), (b) mixture, (c) BQM, (d)
BQD, (e) CBZ-EP, and (f) DI-CBZ. The treatment groups correspond to approximately half (0.5×), equal (1×), and double (2×) the
concentrations measured in ozonated CBZ. *: p < 0.05, **: p < 0.01, ***: p < 0.001. †: all embryos were dead at the time of measurement.
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mixture induced analogous eﬀects (increased proportion of
dead and malformed embryos at 144 hpf, decreased heart rate
at 48 hpf, and prolonged hatching) as the ozonated CBZ
solution in Pohl et al.17 and the present study (Figure 5a). The
1× mixture caused about 80% dead and malformed embryos at
144 hpf (Figure 3b), mainly manifested by yolk-sac edema
(YSE) and pericardial edemas (PE) and lack of swim bladder
inﬂation (SB). The 2× mixture induced lethality in all embryos
already at 24 hpf, while the 0.5× mixture did not produce any
statistically signiﬁcant eﬀects (Figure 3b). The hatching time
delay observed in the previous study (Figure 3a, Pohl et al.17)
was however not reproduced in the present study for OBP
mixture-exposed embryos (Figure 3b). This could well be
because of a high degree of gross malformations and lethality
(87.5%) occurring between 48 and 144 hpf, in the present
study, leading to poor replication and thus low statistical
power.
The measured concentrations in single compound and
mixture exposure solutions in the present study did not
markedly deviate, except for BQD which was measured at
somewhat lower concentrations in the 1× and 2× single
substance exposure solution than in the mixture solution
(Table 2). The overall comparisons of the toxicity of single
compounds and mixtures were therefore not markedly
impaired by large diﬀerences in concentrations in the diﬀerent
solutions (Figure 3). Taken together, the results of the
chemical analyses show the importance of not depending on
nominal concentrations when interpreting results in toxicity
testing.
The present study is the ﬁrst to test the toxic potencies of
BQM and BQD in an in vivo assay. BQM and BQD induced
toxic eﬀects (i.e., reduced heart rate and prolonged hatching
time) similar to what has been observed previously in zebraﬁsh
embryo−larvae exposed to ozonated CBZ (Figure 3a, Pohl et
al.17). The two other tested putative CBZ OBPs (i.e., CBZ-EP
and DI-CBZ) did not aﬀect these endpoints at relevant
concentrations (Figure 3e,f). The results from the tests of the
single OBPs strongly suggest that BQM and BQD were the
drivers of the observed toxicity in the OBP mixture used in the
present study. Toxicity data on CBZ OBPs is currently very
limited. One study has attributed in vitro chromosomal
damage following CBZ ozonation to BQD and BQM based
on QSAR computer modeling.25
3.4. Stability and Embryotoxicity of Pre- and
Postozonated CBZ. Because CBZ has recalcitrant properties
in the aquatic environment,9 we sought to also evaluate the
stability of its main post OBPs. The aim was to study possible
changes in CBZ OBP mixture composition and toxicity under
controlled conditions. The concentrations of CBZ and four
Figure 4.Measured concentrations (mg L−1) of target compounds in (a) tap water control, (b) carbamazepine, and (c) ozonated CBZ in tap water
stored for 0, 1, 24, 168, and 336 h. The gray area signiﬁes target compound LOQ ranges (maximum average LOQ: 0.0025 mg L−1).
Figure 5. (a) Proportion of aﬀected (dead and malformed) zebraﬁsh
embryo−larvae at 144 hpf after exposure to tap water control, 17.5 mg
carbamazepine L−1, and 17.5 mg carbamazepine L−1 + O3 stored for
0, 1, 168, and 336 h in the dark at 22 °C. Signiﬁcant diﬀerences as
compared to controls were indicated by Bonferroni-adjusted Fisher’s
exact test (***: p < 0.001). (b) Images representing embryo−larvae
exposed to tap water control (normal), carbamazepine (normal), and
carbamazepine + O3 (PE, SB, YSE, and general growth retardation) at
144 hpf.
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OBPs were measured in the three diﬀerent treatment solutions
(tap water control, CBZ, and ozonated CBZ) stored in the
dark for 2 weeks at 22 °C (Figure 4). The same solutions were
tested for embryotoxicity in parallel (Figure 5). Measurements
of pH showed no diﬀerence between tap water (8.39 ± 0.01)
and CBZ (8.39 ± 0.01) over the storage period. The pH of
ozonated CBZ was initially lower than that of control and CBZ
(8.18) but reached 8.37 after 336 h storage time. The CBZ
concentration in nonozonated tap water remained stable (18.9
± 1.0 mg L−1) over the whole 2 week storage period (Figure
4b).
The concentration of BQD (5.5 mg L−1), the main formed
OBP screened for in the present study, decreased by 94% after
2 week storage reaching 0.29 mg L−1 (Figure 4c). The second
most formed OBP was BQM, with a concentration remaining
relatively stable over the whole 2 week storage period (2.4 ±
0.3 mg L−1). Both BQD and BQM in ozonated CBZ-spiked
sewage eﬄuent have been reported to continually degrade after
6 day storage in room temperature, transforming into their
respective acid forms BaQM and BaQD, presumably by
microbial processes.27 Only BQD was degraded following
storage of ozonated CBZ-spiked tap water with presumably
negligible microbial activity at room temperature for 2 weeks
in the present study. CBZ-EP remained stable over the storage
period (0.48 ± 0.06 mg L−1). DI-CBZ concentrations also
remained without signiﬁcant reduction both in preozonated
(0.04 ± 0.02 mg L−1) and postozonated (0.02 ± 0.007 mg
L−1) CBZ samples.
The embryotoxicity (reported as % aﬀected (dead and
malformed embryos combined) after 6 d exposure) was tested
at 0, 1, 168, and 336 h postozonation storage time of exposure
mixtures (Figure 5a). The 24 h test was omitted because of
excessive (>10%) spontaneous incidence of dead and
malformed embryos in the tap water control group,
compromising the results of that particular test. CBZ (17.5
mg L−1) did not cause embryotoxicity at any tested storage
time (Figure 5a). Exposure to ozonated CBZ, on the other
hand, signiﬁcantly induced embryotoxicity which remained
throughout the whole storage period (Figure 5a). However,
embryotoxicity decreased from ∼95% at 0 h to ∼75% at 336 h
storage time, which is possibly linked to the BQD
concentration reduction (94%) between 0 and 336 h storage
time (Figure 4c). The embryotoxicity observed in the
ozonated CBZ treatment group was mainly manifested by
PE and YSEs appearing between 48 and 144 hpf (Figure 5b).
Furthermore, embryos exposed to ozonated CBZ failed to
hatch and properly inﬂate the swim bladder at 144 hpf at a
larger extent than CBZ and tap water control. These results are
in agreement with our previous study where CBZ ozonation
under the same conditions resulted in equivalent malforma-
tions.17 Moreover, the same malformation types were
predominant in embryos exposed to BQD, BQM, and the
mixture (Figure 3). Residual ozone has been shown not to
aﬀect developing zebraﬁsh embryos at the concentrations used
in the present study.17
In practice, the toxicity of CBZ following ozonation may be
negated by applying, for example, ﬁltration steps after
ozonation. Subsequent biodegradation in a sand column has
for instance been shown to be eﬀective for the removal of
BQD, BQM, and BaQM.27 The results of the present study, in
general, reﬂect the situation occurring in a lab-scale reactor at
CBZ concentrations 100−1000-fold above environmental
relevance. Assessing the real-life situation in recipient surface
waters, where sewage eﬄuents have been treated with O3, thus
producing BQM and BQD, lies outside the scope of the
present study. Other factors inﬂuencing chemical stability,
including, for example, photodegradation, may also aﬀect OBP
concentrations over time. Nevertheless, because the elevated
CBZ embryotoxicity after ozonation remains even after 2 week
storage at room temperature, a continuous release of toxic
OBPs (i.e., BQM) to the recipient may be problematic.
Further research eﬀorts should, therefore, focus on bioaccu-
mulation properties and the long-term environmental eﬀects of
CBZ OBPs. Of particular interest is BQM, which displayed
chemical stability and higher toxicity than the parent
compound CBZ. The toxicity mechanisms of the OBPs should
be unveiled as well. As we applied a target analysis approach,
there is a possibility we might have overlooked other OBPs
which may be responsible for additional toxicity. Conse-
quently, the application of a nontarget screening approach will
also be valuable in future studies.
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Pharmaceuticals pollute the aquatic environment, causing adverse effects in fish and 
other organisms. Implementing ozonation as a sewage treatment is a potential approach 
to improve pharmaceutical removal. This thesis evaluated ozonation of a sewage effluent 
and selected pharmaceuticals in zebrafish (Danio rerio). Ozone treatment gave rise to 
diverging toxicity outcomes, both beneficial and adverse. Consequently, the formation 
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